cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
GBM	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.47	5.4	3.15E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs10006789	chr4:1330333	CRIPAK	chr4:1385340-1389782:+	0.42	4.92	2.61E-6	Systolic blood pressure	
GBM	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.57	-6.95	1.71E-10	Longevity	
GBM	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.33	-4.18	5.49E-5	Eye color traits	
GBM	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.64	-5.62	1.18E-7	Rheumatoid arthritis	
GBM	cis	1	rs10119803	chr9:21666066	KLHL9	chr9:21324054-21335429:-	-0.51	-4.16	5.83E-5	Gut microbiome composition (winter)	
GBM	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.37	-5.11	1.18E-6	Common traits (Other)	
GBM	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.41	-5.54	1.66E-7	Common traits (Other)	
GBM	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.38	-5.25	6.17E-7	Common traits (Other)	
GBM	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.44	-5.61	1.2E-7	Homocysteine levels	
GBM	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.69	8.7	1.57E-14	Response to antipsychotic treatment	
GBM	cis	1	rs10185421	chr2:137537699	THSD7B	chr2:137523115-138435287:+	-0.45	-4.24	4.35E-5	Pancreatic cancer	
GBM	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	0.7	7.78	2.23E-12	Diastolic blood pressure	
GBM	cis	1	rs10216533	chr8:143763690	PSCA	chr8:143761875-143764142:+	0.56	5	1.89E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.71	4.69	7.02E-6	Coronary heart disease	
GBM	cis	1	rs10228845	chr7:21583617	DNAH11	chr7:21582833-21941455:+	-0.58	-6.33	4.03E-9	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
GBM	cis	1	rs10229224	chr7:21583921	DNAH11	chr7:21582833-21941455:+	-0.59	-6.4	2.78E-9	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
GBM	cis	1	rs1025646	chr3:41754422	ULK4	chr3:41288091-42003660:-	0.82	8.23	1.99E-13	Diastolic blood pressure	
GBM	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.49	-5.68	8.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1034219	chr1:93022678	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.49	-5.68	8.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1040726	chr20:3264267	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs1040727	chr20:3264292	ITPA	chr20:3190056-3204504:+	-0.55	-5.39	3.32E-7	IFN-related cytopenia	
GBM	cis	1	rs10416218	chr19:33599127	GPATCH1	chr19:33571786-33621318:+	0.4	4.5	1.54E-5	Bone properties (heel)	
GBM	cis	1	rs10416218	chr19:33599127	RHPN2	chr19:33469499-33555824:-	-0.38	-4.24	4.27E-5	Bone properties (heel)	
GBM	cis	1	rs10416265	chr19:33605300	GPATCH1	chr19:33571786-33621318:+	0.42	4.6	1.0E-5	Bone properties (heel)	
GBM	cis	1	rs10416265	chr19:33605300	RHPN2	chr19:33469499-33555824:-	-0.41	-4.44	1.98E-5	Bone properties (heel)	
GBM	cis	1	rs10423531	chr19:33600140	GPATCH1	chr19:33571786-33621318:+	0.4	4.5	1.54E-5	Bone properties (heel)	
GBM	cis	1	rs10423531	chr19:33600140	RHPN2	chr19:33469499-33555824:-	-0.38	-4.24	4.27E-5	Bone properties (heel)	
GBM	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.76	-8.43	6.86E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.51	4.26	3.94E-5	Multiple sclerosis	
GBM	cis	1	rs10437345	chr10:65202946	NRBF2	chr10:64893007-64914785:+	-0.53	-5.08	1.35E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.4	-5.31	4.78E-7	Esophageal cancer (squamous cell)	
GBM	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.45	-5.56	1.52E-7	Homocysteine levels	
GBM	cis	1	rs10454142	chr2:48646399	GTF2A1L	chr2:48844948-48960284:+	-0.6	-5.01	1.76E-6	Sex hormone-binding globulin levels	
GBM	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.66	-8.47	5.53E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1045531	chr8:143763547	PSCA	chr8:143761875-143764142:+	0.56	5	1.89E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.69	-8.19	2.53E-13	Response to antipsychotic treatment	
GBM	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.66	-8.55	3.5E-14	Response to antipsychotic treatment	
GBM	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.66	-8.52	4.18E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1045547	chr8:143763757	PSCA	chr8:143761875-143764142:+	0.56	5	1.89E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs1045574	chr8:143763958	PSCA	chr8:143761875-143764142:+	0.55	5.06	1.43E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs1045605	chr8:143764101	PSCA	chr8:143761875-143764142:+	0.56	5.01	1.83E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs1046073	chr20:25281333	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.92	9.97	1.28E-17	Type 2 diabetes	
GBM	cis	1	rs10465756	chr1:93029698	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.41	-5.48	2.25E-7	Longevity	
GBM	cis	1	rs1047171	chr20:25428786	FAM182A	chr20:26035250-26067552:+	-0.65	-6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs10494874	chr1:205754688	PM20D1	chr1:205797154-205819245:-	-0.52	-4.32	3.15E-5	Prostate-specific antigen levels	
GBM	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.68	8.9	5.08E-15	Response to antipsychotic treatment	
GBM	cis	1	rs10508206	chr10:1075777	IDI2	chr10:1064847-1071799:-	-0.56	-5.22	7.2E-7	Response to angiotensin II receptor blocker therapy	
GBM	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.71	-8.35	1.04E-13	Diastolic blood pressure	
GBM	cis	1	rs10733790	chr10:65100334	NRBF2	chr10:64893007-64914785:+	-0.61	-5.19	8.3E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.49	5.57	1.5E-7	Pancreatic cancer	
GBM	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.41	5.2	7.71E-7	Homocysteine levels	
GBM	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.54	-5.45	2.54E-7	Hematology traits	
GBM	cis	1	rs10740117	chr10:65098277	ADO	chr10:64564516-64568238:+	-0.49	-4.3	3.39E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs10740117	chr10:65098277	NRBF2	chr10:64893007-64914785:+	-0.66	-5.79	5.37E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.43	-4.86	3.44E-6	Pancreatic cancer	
GBM	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.48	5.31	4.84E-7	Pancreatic cancer	
GBM	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.57	4.61	9.63E-6	Multiple sclerosis	
GBM	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.4	4.24	4.24E-5	Height	
GBM	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.52	-5.3	5.1E-7	Hematology traits	
GBM	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.65	-5.9	3.19E-8	Rheumatoid arthritis	
GBM	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.64	-5.65	1.03E-7	Rheumatoid arthritis	
GBM	cis	1	rs10761745	chr10:65101071	NRBF2	chr10:64893007-64914785:+	-0.52	-4.88	3.21E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs1077889	chr20:25267893	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs10782922	chr1:92974595	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.51	4.26	3.94E-5	Multiple sclerosis	
GBM	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.51	4.26	3.94E-5	Multiple sclerosis	
GBM	cis	1	rs10784534	chr12:66829726	CAND1	chr12:67663061-67708388:+	-0.42	-4.32	3.12E-5	Suicidal ideation in depression or bipolar disorder	
GBM	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.63	-5.68	8.96E-8	Rheumatoid arthritis	
GBM	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.49	5.47	2.32E-7	Pancreatic cancer	
GBM	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.34	-4.27	3.75E-5	Lung cancer	
GBM	cis	1	rs10863512	chr1:220075215	BPNT1	chr1:220230826-220263191:-	0.37	4.19	5.22E-5	Urinary electrolytes (magnesium/calcium ratio)	
GBM	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.76	-8.97	3.53E-15	Diastolic blood pressure	
GBM	cis	1	rs10872275	chr6:124236735	NKAIN2	chr6:124125069-125146784:+	0.3	4.22	4.65E-5	Gut microbiome composition (summer)	
GBM	cis	1	rs10874122	chr1:75235866	CRYZ	chr1:75171175-75199092:-	-0.53	-7.16	5.98E-11	Resistin levels	
GBM	cis	1	rs10874656	chr1:92947024	EVI5	chr1:92974255-93257961:-	-0.55	-4.95	2.3E-6	Cholesterol, total	
GBM	cis	1	rs10883500	chr10:102238324	TLX1	chr10:102891061-102897545:+	0.43	4.18	5.48E-5	Palmitoleic acid (16:1n-7) plasma levels	
GBM	cis	1	rs10883501	chr10:102238326	TLX1	chr10:102891061-102897545:+	0.43	4.18	5.48E-5	Palmitoleic acid (16:1n-7) plasma levels	
GBM	cis	1	rs10883502	chr10:102238343	TLX1	chr10:102891061-102897545:+	0.43	4.18	5.48E-5	Palmitoleic acid (16:1n-7) plasma levels	
GBM	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.65	-8.18	2.66E-13	Response to antipsychotic treatment	
GBM	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.67	-8.58	2.92E-14	Response to antipsychotic treatment	
GBM	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.66	-8.52	4.18E-14	Response to antipsychotic treatment	
GBM	cis	1	rs10966	chr20:25282944	FAM182A	chr20:26035250-26067552:+	-0.66	-6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs10995506	chr10:65094466	ADO	chr10:64564516-64568238:+	-0.49	-4.3	3.39E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs10995506	chr10:65094466	NRBF2	chr10:64893007-64914785:+	-0.66	-5.79	5.37E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs10995543	chr10:65239547	JMJD1C	chr10:64926990-65225722:-	0.41	4.19	5.12E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs10995543	chr10:65239547	NRBF2	chr10:64893007-64914785:+	0.61	5.64	1.08E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs11020847	chr11:94323912	MRE11A	chr11:94150469-94227040:-	0.41	4.31	3.21E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
GBM	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.6	4.67	7.56E-6	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs11079508	chr17:61750066	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs11079509	chr17:61762148	FTSJ3	chr17:61896795-61905031:-	0.43	4.75	5.43E-6	Body mass index	
GBM	cis	1	rs11079511	chr17:61858537	FTSJ3	chr17:61896795-61905031:-	0.47	5.12	1.11E-6	Body mass index	
GBM	cis	1	rs1108431	chr16:31054607	MYST1	chr16:31128985-31142713:+	0.41	4.56	1.18E-5	Response to metformin (IC50)	
GBM	cis	1	rs11087520	chr20:25436827	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs11087521	chr20:25440648	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.35E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.41	-5.55	1.64E-7	Longevity	
GBM	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.59	4.56	1.19E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs11100	chr20:25281184	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.67	-6.53	1.48E-9	Renal function-related traits (BUN)	
GBM	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.58	-5.7	7.88E-8	Renal function-related traits (BUN)	
GBM	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.41	-5.49	2.12E-7	Longevity	
GBM	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.44	-5.84	4.1E-8	Longevity	
GBM	cis	1	rs11130213	chr3:49712297	LAMB2L	chr3:49190293-49191834:-	0.48	4.52	1.38E-5	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs11130214	chr3:49735746	RBM6	chr3:49977592-50137484:+	0.35	5.18	8.63E-7	Resting heart rate	
GBM	cis	1	rs11130216	chr3:49736172	RBM6	chr3:49977592-50137484:+	-0.36	-5.09	1.29E-6	Resting heart rate	
GBM	cis	1	rs111315781	chr2:201738724	CFLAR	chr2:201980816-202029001:+	-0.51	-4.33	3.0E-5	Triptolide cytotoxicity	
GBM	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.78	-7.21	4.55E-11	Triptolide cytotoxicity	
GBM	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.37	-5.63	1.1E-7	Kawasaki disease	
GBM	cis	1	rs11154197	chr6:124240102	NKAIN2	chr6:124125069-125146784:+	-0.3	-4.43	2.03E-5	Gut microbiome composition (summer)	
GBM	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.43	5.73	6.84E-8	Common traits (Other)	
GBM	cis	1	rs111596617	chr6:26191678	HIST1H3E	chr6:26224427-26226589:+	0.85	5.67	9.22E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs11164654	chr1:92968312	EVI5	chr1:92974255-93257961:-	-0.55	-4.95	2.3E-6	Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.56	4.39	2.34E-5	Multiple sclerosis	
GBM	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.57	4.51	1.48E-5	Multiple sclerosis	
GBM	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.57	4.51	1.48E-5	Multiple sclerosis	
GBM	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.51	4.26	3.94E-5	Multiple sclerosis	
GBM	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.6	4.72	6.24E-6	Multiple sclerosis	
GBM	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.6	4.74	5.69E-6	Multiple sclerosis	
GBM	cis	1	rs11190570	chr10:102227702	TLX1	chr10:102891061-102897545:+	0.44	4.23	4.43E-5	Palmitoleic acid (16:1n-7) plasma levels	
GBM	cis	1	rs11190578	chr10:102238953	TLX1	chr10:102891061-102897545:+	0.45	4.19	5.18E-5	Palmitoleic acid (16:1n-7) plasma levels	
GBM	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.43	-5.48	2.27E-7	Homocysteine levels	
GBM	cis	1	rs112143304	chr17:61822401	FTSJ3	chr17:61896795-61905031:-	0.45	4.94	2.41E-6	Body mass index	
GBM	cis	1	rs1125203	chr3:41760895	ULK4	chr3:41288091-42003660:-	0.79	8.39	8.44E-14	Diastolic blood pressure	
GBM	cis	1	rs112723723	chr15:79031139	ADAMTS7	chr15:79051546-79103773:-	0.34	4.32	3.09E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs112751982	chr6:26191958	HIST1H3E	chr6:26224427-26226589:+	0.85	5.67	9.22E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs112953061	chr7:106718508	COG5	chr7:106842189-107204959:-	-0.6	-4.25	4.07E-5	Bladder cancer (smoking interaction)	
GBM	cis	1	rs1131095	chr3:49714225	LAMB2L	chr3:49190293-49191834:-	0.48	4.52	1.38E-5	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs113134232	chr17:61715461	FTSJ3	chr17:61896795-61905031:-	0.44	4.78	4.82E-6	Body mass index	
GBM	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.36	-4.82	4.08E-6	Esophageal cancer (squamous cell)	
GBM	cis	1	rs113638727	chr15:40706101	C15orf23	chr15:40674922-40686488:+	0.65	4.78	4.81E-6	Heschl's gyrus morphology	
GBM	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.49	5.57	1.5E-7	Pancreatic cancer	
GBM	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs11542436	chr17:61778689	FTSJ3	chr17:61896795-61905031:-	0.43	4.73	5.99E-6	Body mass index	
GBM	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	0.65	4.78	4.81E-6	Heschl's gyrus morphology	
GBM	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.33	4.52	1.39E-5	Common traits (Other)	
GBM	cis	1	rs11632672	chr15:79044330	ADAMTS7	chr15:79051546-79103773:-	0.33	4.25	4.11E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.68	-8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.68	8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs11654335	chr17:61797579	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs11657081	chr17:61792339	FTSJ3	chr17:61896795-61905031:-	0.45	5.05	1.53E-6	Body mass index	
GBM	cis	1	rs11657120	chr17:61857218	FTSJ3	chr17:61896795-61905031:-	0.46	5.17	8.9E-7	Body mass index	
GBM	cis	1	rs11657306	chr17:61704822	FTSJ3	chr17:61896795-61905031:-	0.43	4.75	5.54E-6	Body mass index	
GBM	cis	1	rs11657371	chr17:46843873	SNX11	chr17:46184911-46200105:+	0.34	4.33	3.0E-5	Schizophrenia or bipolar disorder	
GBM	cis	1	rs11658175	chr17:61923838	FTSJ3	chr17:61896795-61905031:-	0.48	5.51	1.97E-7	Body mass index	
GBM	cis	1	rs11658329	chr17:61763031	FTSJ3	chr17:61896795-61905031:-	-0.42	-4.68	7.28E-6	Body mass index	
GBM	cis	1	rs11658740	chr17:61751069	FTSJ3	chr17:61896795-61905031:-	0.44	4.88	3.09E-6	Body mass index	
GBM	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.68	-8.86	6.36E-15	Body mass index	
GBM	cis	1	rs116867513	chr19:22166026	ZNF257	chr19:22235266-22273901:+	0.67	4.41	2.21E-5	Body mass index (change over time)	
GBM	cis	1	rs11709525	chr3:49690496	LAMB2L	chr3:49190293-49191834:-	0.54	5.12	1.1E-6	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs11710675	chr3:49751900	RBM6	chr3:49977592-50137484:+	-0.36	-5.08	1.34E-6	Resting heart rate	
GBM	cis	1	rs11710675	chr3:49751900	WDR6	chr3:49044637-49053386:+	-0.3	-4.23	4.49E-5	Resting heart rate	
GBM	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.4	-5.35	3.94E-7	Longevity	
GBM	cis	1	rs11717256	chr3:49868520	RBM6	chr3:49977592-50137484:+	-0.36	-5.1	1.23E-6	Resting heart rate	
GBM	cis	1	rs11717256	chr3:49868520	WDR6	chr3:49044637-49053386:+	-0.33	-4.52	1.42E-5	Resting heart rate	
GBM	cis	1	rs11718165	chr3:49696797	LAMB2L	chr3:49190293-49191834:-	0.49	4.39	2.37E-5	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs11733284	chr4:48028097	CNGA1	chr4:47937996-48018610:-	0.62	6.08	1.36E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs11737481	chr4:159621250	ETFDH	chr4:159593277-159629839:+	0.45	4.22	4.56E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
GBM	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs11753083	chr6:33761111	LEMD2	chr6:33738991-33756906:-	0.41	4.92	2.66E-6	Body mass index	
GBM	cis	1	rs11754690	chr6:33744157	LEMD2	chr6:33738991-33756906:-	0.41	4.94	2.46E-6	Body mass index	
GBM	cis	1	rs11754744	chr6:26202605	HIST1H3E	chr6:26224427-26226589:+	0.87	5.74	6.68E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs11755210	chr6:26202768	HIST1H3E	chr6:26224427-26226589:+	0.87	5.74	6.68E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs11755593	chr6:33740325	LEMD2	chr6:33738991-33756906:-	0.41	4.81	4.31E-6	Body mass index	
GBM	cis	1	rs11758351	chr6:26203910	HIST1H3E	chr6:26224427-26226589:+	0.84	5.53	1.8E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.66	-8.21	2.28E-13	Response to antipsychotic treatment	
GBM	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.66	-8.57	3.18E-14	Response to antipsychotic treatment	
GBM	cis	1	rs11763147	chr7:65326821	ZNF117	chr7:64434830-64467121:-	-0.34	-4.42	2.08E-5	Corneal structure	
GBM	cis	1	rs117638181	chr19:22163014	ZNF257	chr19:22235266-22273901:+	0.64	4.23	4.45E-5	Body mass index (change over time)	
GBM	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.67	-8.28	1.53E-13	Response to antipsychotic treatment	
GBM	cis	1	rs11814792	chr10:64917559	NRBF2	chr10:64893007-64914785:+	0.58	4.91	2.74E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs11817689	chr10:64924217	NRBF2	chr10:64893007-64914785:+	-0.5	-4.73	5.94E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs11818194	chr10:65180452	NRBF2	chr10:64893007-64914785:+	0.53	4.84	3.77E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.71	-4.8	4.37E-6	Tumor biomarkers	
GBM	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	0.75	5.43	2.84E-7	Heschl's gyrus morphology	
GBM	cis	1	rs11862744	chr16:31057800	MYST1	chr16:31128985-31142713:+	0.38	4.47	1.71E-5	Response to metformin (IC50)	
GBM	cis	1	rs11868085	chr17:46847575	SNX11	chr17:46184911-46200105:+	0.33	4.29	3.59E-5	Schizophrenia or bipolar disorder	
GBM	cis	1	rs11870797	chr17:61804622	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs11871767	chr17:61698723	FTSJ3	chr17:61896795-61905031:-	0.43	4.74	5.78E-6	Body mass index	
GBM	cis	1	rs11881224	chr19:22220340	ZNF257	chr19:22235266-22273901:+	0.67	4.72	6.11E-6	Body mass index (change over time)	
GBM	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.64	6.1	1.21E-8	Schizophrenia	
GBM	cis	1	rs11882234	chr19:22145727	ZNF257	chr19:22235266-22273901:+	0.68	4.73	5.99E-6	Body mass index (change over time)	
GBM	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.75	-4.5	1.55E-5	Plasma clusterin levels	
GBM	cis	1	rs11920900	chr3:49823024	RBM6	chr3:49977592-50137484:+	-0.35	-4.94	2.43E-6	Resting heart rate	
GBM	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.77	7.69	3.58E-12	Diastolic blood pressure	
GBM	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.74	8.72	1.35E-14	Diastolic blood pressure	
GBM	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	1.03	10.34	1.61E-18	Educational attainment (years of education)	
GBM	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.61	4.68	7.18E-6	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.61	4.68	7.18E-6	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.61	4.68	7.18E-6	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.61	4.68	7.18E-6	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.57	4.42	2.08E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.61	4.68	7.18E-6	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.59	4.56	1.19E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.68	-8.05	5.38E-13	Response to antipsychotic treatment	
GBM	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.67	-8.33	1.18E-13	Response to antipsychotic treatment	
GBM	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.66	-8.57	3.18E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.65	-8.18	2.66E-13	Response to antipsychotic treatment	
GBM	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.7	-8.25	1.8E-13	Response to antipsychotic treatment	
GBM	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.7	-8.67	1.77E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.7	-8.67	1.77E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.68	-8.82	7.84E-15	Response to antipsychotic treatment	
GBM	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.66	-8.57	3.18E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.68	-8.77	1.03E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.68	-8.51	4.35E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.71	-8.74	1.21E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.71	-8.74	1.21E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.66	-8.21	2.28E-13	Response to antipsychotic treatment	
GBM	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.66	-8.54	3.73E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.7	-8.53	3.97E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.71	-8.78	1.01E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.7	-8.67	1.77E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.66	-8.58	2.89E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.7	-8.53	3.97E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.7	-8.53	3.97E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.66	-8.58	2.89E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.68	-8.74	1.25E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.7	-8.56	3.38E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.62	-7.87	1.41E-12	Response to antipsychotic treatment	
GBM	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.66	-8.53	3.87E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.67	-8.62	2.43E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.48	5.43	2.78E-7	Pancreatic cancer	
GBM	cis	1	rs12301299	chr12:991710	RAD52	chr12:1021255-1099219:-	-0.46	-4.53	1.36E-5	Colorectal cancer	
GBM	cis	1	rs12309274	chr12:975948	RAD52	chr12:1021255-1099219:-	-0.45	-4.33	2.99E-5	Colorectal cancer	
GBM	cis	1	rs12312603	chr12:988269	RAD52	chr12:1021255-1099219:-	-0.56	-5.33	4.34E-7	Colorectal cancer	
GBM	cis	1	rs12325866	chr17:61755974	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs12355721	chr10:102244911	TLX1	chr10:102891061-102897545:+	0.46	4.5	1.53E-5	Palmitoleic acid (16:1n-7) plasma levels	
GBM	cis	1	rs12410060	chr1:75245848	CRYZ	chr1:75171175-75199092:-	-0.53	-7.18	5.45E-11	Resistin levels	
GBM	cis	1	rs12411988	chr10:65315397	NRBF2	chr10:64893007-64914785:+	-0.56	-5.19	8.15E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12412012	chr10:65315763	NRBF2	chr10:64893007-64914785:+	0.72	6.04	1.6E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12413029	chr10:65189126	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12413415	chr10:64919511	NRBF2	chr10:64893007-64914785:+	0.59	5.28	5.43E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12413730	chr10:64964148	NRBF2	chr10:64893007-64914785:+	0.58	4.94	2.42E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12414159	chr10:65238777	JMJD1C	chr10:64926990-65225722:-	0.41	4.19	5.12E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12414159	chr10:65238777	NRBF2	chr10:64893007-64914785:+	0.61	5.64	1.08E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12414796	chr10:65303087	NRBF2	chr10:64893007-64914785:+	0.68	6.13	1.04E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12415038	chr10:65160858	NRBF2	chr10:64893007-64914785:+	0.58	5.11	1.15E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12415984	chr10:64910288	NRBF2	chr10:64893007-64914785:+	0.68	5.56	1.51E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12416349	chr10:65277543	NRBF2	chr10:64893007-64914785:+	0.66	5.97	2.26E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12422267	chr12:132601596	DDX51	chr12:132621142-132628880:-	0.47	4.37	2.59E-5	Plasma amyloid beta peptide concentrations (ABx-40)	
GBM	cis	1	rs12428	chr20:25433821	FAM182A	chr20:26035250-26067552:+	0.62	6.04	1.61E-8	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs12442510	chr15:66099113	SLC24A1	chr15:65903704-65953256:+	0.27	4.39	2.39E-5	Mean corpuscular hemoglobin	
GBM	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.71	-4.8	4.37E-6	Tumor biomarkers	
GBM	cis	1	rs12445650	chr16:31044897	MYST1	chr16:31128985-31142713:+	0.38	4.46	1.76E-5	Response to metformin (IC50)	
GBM	cis	1	rs12446632	chr16:19935389	C16orf88	chr16:19717676-19729492:-	0.74	5.11	1.15E-6	Body mass index;Menarche (age at onset);Childhood body mass index;Obesity	
GBM	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.72	-4.96	2.24E-6	Plasma clusterin levels	
GBM	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.4	-5.34	4.13E-7	Longevity	
GBM	cis	1	rs12517431	chr5:156392248	TIMD4	chr5:156346293-156390266:-	-0.5	-5.38	3.46E-7	Triglycerides;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs12524768	chr6:33760478	LEMD2	chr6:33738991-33756906:-	0.4	4.95	2.31E-6	Body mass index	
GBM	cis	1	rs12524835	chr6:33730843	LEMD2	chr6:33738991-33756906:-	0.43	5.06	1.47E-6	Body mass index	
GBM	cis	1	rs12530266	chr6:124236284	NKAIN2	chr6:124125069-125146784:+	-0.29	-4.26	4.0E-5	Gut microbiome composition (summer)	
GBM	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.41	-4.24	4.29E-5	Forced vital capacity	
GBM	cis	1	rs12620050	chr2:108919798	SULT1C2	chr2:108905095-108926370:+	0.62	5.96	2.33E-8	Lobe size	
GBM	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs12657266	chr5:156396003	TIMD4	chr5:156346293-156390266:-	-0.5	-5.37	3.64E-7	Triglycerides;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.65	-8.13	3.53E-13	Response to antipsychotic treatment	
GBM	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.66	-8.54	3.73E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.68	8.11	3.76E-13	Response to antipsychotic treatment	
GBM	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.69	8.68	1.73E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.71	-8.78	1.01E-14	Response to antipsychotic treatment	
GBM	cis	1	rs12784772	chr10:65195455	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs12904489	chr15:79033925	ADAMTS7	chr15:79051546-79103773:-	0.34	4.33	3.0E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs12906977	chr15:79031329	ADAMTS7	chr15:79051546-79103773:-	0.33	4.19	5.15E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs12907207	chr15:79031290	ADAMTS7	chr15:79051546-79103773:-	0.33	4.19	5.15E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs12907536	chr15:79031485	ADAMTS7	chr15:79051546-79103773:-	0.33	4.19	5.15E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs12910992	chr15:90372465	AP3S2	chr15:90373832-90456222:-	-0.6	-5.13	1.05E-6	Type 2 diabetes	
GBM	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.7	8.27	1.58E-13	Eye color traits	
GBM	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.42	4.5	1.52E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
GBM	cis	1	rs13038834	chr20:25441433	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.35E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.42	-5.65	1.03E-7	Longevity	
GBM	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.4	-5.34	4.13E-7	Longevity	
GBM	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.44	-5.85	4.0E-8	Longevity	
GBM	cis	1	rs13085791	chr3:49721798	LAMB2L	chr3:49190293-49191834:-	0.48	4.52	1.38E-5	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-0.72	-8.39	8.5E-14	Diastolic blood pressure	
GBM	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.41	-5.51	1.91E-7	Longevity	
GBM	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.47	-5.47	2.35E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs13120847	chr4:48030036	CNGA1	chr4:47937996-48018610:-	0.61	5.98	2.19E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs13125949	chr4:48026560	CNGA1	chr4:47937996-48018610:-	0.62	6.08	1.36E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.49	-5.68	8.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.67	6.66	7.78E-10	Renal underexcretion gout;Gout	
GBM	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.62	6.08	1.36E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs13146880	chr4:48031499	CNGA1	chr4:47937996-48018610:-	0.57	5.6	1.28E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.68	-8.81	8.59E-15	Response to antipsychotic treatment	
GBM	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.67	-8.78	9.71E-15	Response to antipsychotic treatment	
GBM	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.65	-8.25	1.84E-13	Response to antipsychotic treatment	
GBM	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.7	-8.73	1.31E-14	Response to antipsychotic treatment	
GBM	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.69	7.93	1.03E-12	Bone mineral density	
GBM	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.68	7.81	1.9E-12	Bone mineral density	
GBM	cis	1	rs1331215	chr20:3376565	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.42	5.7	7.99E-8	Longevity	
GBM	cis	1	rs13316695	chr3:49684917	LAMB2L	chr3:49190293-49191834:-	0.51	4.83	3.85E-6	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.81	8.45	5.93E-14	Diastolic blood pressure	
GBM	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.66	-8.42	7.33E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.7	-8.53	3.97E-14	Response to antipsychotic treatment	
GBM	cis	1	rs13380863	chr17:61780793	FTSJ3	chr17:61896795-61905031:-	0.47	5.09	1.29E-6	Body mass index	
GBM	cis	1	rs13384952	chr2:73723959	ALMS1P	chr2:73872046-73912692:+	-0.54	-4.59	1.05E-5	Metabolite levels	
GBM	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.57	-5.28	5.57E-7	Prostate cancer	
GBM	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.74	5.67	9.41E-8	Rheumatoid arthritis	
GBM	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.74	-6.24	6.22E-9	Rheumatoid arthritis	
GBM	cis	1	rs13410305	chr2:108912673	SULT1C2	chr2:108905095-108926370:+	0.62	6.21	7.18E-9	Lobe size	
GBM	cis	1	rs1341759	chr6:26195502	HIST1H3E	chr6:26224427-26226589:+	0.85	5.67	9.22E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.43	-5.32	4.51E-7	Cognitive function	
GBM	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.43	-5.27	5.72E-7	Cognitive function	
GBM	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.45	-5.19	8.12E-7	Cognitive function	
GBM	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.42	-5.39	3.35E-7	Cognitive function	
GBM	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.39	-4.98	2.06E-6	Cognitive function	
GBM	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.81	-7.11	7.62E-11	Type 2 diabetes	
GBM	cis	1	rs138544659	chr15:78900701	CHRNA5	chr15:78857906-78886458:+	-0.46	-4.49	1.62E-5	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
GBM	cis	1	rs1391708	chr12:57305580	ESYT1	chr12:56522054-56538452:+	-0.48	-4.3	3.35E-5	Airway wall thickness	
GBM	cis	1	rs1406947	chr20:33969530	CPNE1	chr20:34213968-34262539:-	0.56	5.47	2.33E-7	Height	
GBM	cis	1	rs1408916	chr1:92992627	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs141518190	chr15:78900647	CHRNA5	chr15:78857906-78886458:+	-0.46	-4.49	1.62E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
GBM	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.71	-8.74	1.21E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.92	10.13	5.3E-18	Type 2 diabetes	
GBM	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.9	10.06	8.0E-18	Type 2 diabetes	
GBM	cis	1	rs144073979	chr22:18886814	DGCR6	chr22:18893541-18899600:+	-1.06	-6.66	7.74E-10	3-hydroxypropylmercapturic acid levels in smokers	
GBM	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.38	5.05	1.51E-6	Longevity	
GBM	cis	1	rs147499554	chr15:78900650	CHRNA5	chr15:78857906-78886458:+	-0.46	-4.49	1.62E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
GBM	cis	1	rs1501908	chr5:156398169	TIMD4	chr5:156346293-156390266:-	0.51	5.53	1.75E-7	Triglycerides;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs1509123	chr17:6683878	PITPNM3	chr17:6354584-6459877:-	-0.74	-4.42	2.1E-5	Blood metabolite levels	
GBM	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.59	-7.5	9.93E-12	Ankylosing spondylitis	
GBM	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.5	4.88	3.12E-6	Ankylosing spondylitis	
GBM	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.48	-5.48	2.24E-7	Pancreatic cancer	
GBM	cis	1	rs1540927	chr20:33931344	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs1554120	chr3:150935371	CLRN1OS	chr3:150570271-150797617:+	-0.72	-4.72	6.15E-6	Heschl's gyrus morphology	
GBM	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.38	-5.04	1.57E-6	Esophageal cancer (squamous cell)	
GBM	cis	1	rs1556562	chr1:93034023	EVI5	chr1:92974255-93257961:-	0.54	4.95	2.31E-6	Cholesterol, total	
GBM	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.92	10.09	6.67E-18	Type 2 diabetes	
GBM	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.4	-5.34	4.13E-7	Longevity	
GBM	cis	1	rs15637	chr17:61772050	FTSJ3	chr17:61896795-61905031:-	0.43	4.74	5.7E-6	Body mass index	
GBM	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs1570004	chr20:33958253	CPNE1	chr20:34213968-34262539:-	0.57	5.63	1.14E-7	Height	
GBM	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.46	4.45	1.87E-5	Height	
GBM	cis	1	rs1570836	chr1:92972457	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs1570837	chr1:93006816	EVI5	chr1:92974255-93257961:-	-0.53	-4.78	4.72E-6	Cholesterol, total	
GBM	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.65	-8.18	2.66E-13	Response to antipsychotic treatment	
GBM	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.71	-8.74	1.21E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.57	4.51	1.48E-5	Multiple sclerosis	
GBM	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.75	8.78	9.65E-15	Diastolic blood pressure	
GBM	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.67	-6.04	1.62E-8	Rheumatoid arthritis	
GBM	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.72	-7.76	2.59E-12	Diastolic blood pressure	
GBM	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.75	8.78	9.65E-15	Diastolic blood pressure	
GBM	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.72	-8.4	7.82E-14	Diastolic blood pressure	
GBM	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.75	8.78	9.65E-15	Diastolic blood pressure	
GBM	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-0.72	-8.39	8.5E-14	Diastolic blood pressure	
GBM	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.71	-8.35	1.04E-13	Diastolic blood pressure	
GBM	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.5	-4.37	2.54E-5	Rheumatoid arthritis	
GBM	cis	1	rs16837131	chr2:202173812	CFLAR	chr2:201980816-202029001:+	0.62	4.64	8.64E-6	Rheumatoid arthritis	
GBM	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.79	6.19	7.98E-9	Rheumatoid arthritis	
GBM	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.68	-8.25	1.84E-13	Response to antipsychotic treatment	
GBM	cis	1	rs16891378	chr6:26188864	HIST1H3E	chr6:26224427-26226589:+	0.78	5.36	3.81E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs16891397	chr6:26200256	HIST1H3E	chr6:26224427-26226589:+	0.81	5.46	2.4E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs16891401	chr6:26202337	HIST1H3E	chr6:26224427-26226589:+	0.84	5.53	1.73E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs16891405	chr6:26204506	HIST1H3E	chr6:26224427-26226589:+	0.82	5.37	3.6E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs16918567	chr10:65294670	NRBF2	chr10:64893007-64914785:+	0.68	6.13	1.04E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs16918573	chr10:65300805	NRBF2	chr10:64893007-64914785:+	0.68	6.13	1.04E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs16918575	chr10:65301325	NRBF2	chr10:64893007-64914785:+	-0.64	-5.77	5.84E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs16918599	chr10:65320079	NRBF2	chr10:64893007-64914785:+	0.72	6.08	1.3E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs16947005	chr17:61702989	FTSJ3	chr17:61896795-61905031:-	-0.45	-4.94	2.47E-6	Body mass index	
GBM	cis	1	rs16947014	chr17:61719032	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs16947042	chr17:61766457	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.39	-5.25	6.4E-7	Esophageal cancer (squamous cell)	
GBM	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.48	-5.57	1.46E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.49	-5.7	7.97E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.49	-5.7	7.97E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.49	-5.68	8.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.48	-5.69	8.51E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.49	-5.7	7.97E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.61	4.72	6.17E-6	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.57	4.42	2.08E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.82	8.86	6.49E-15	Diastolic blood pressure	
GBM	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.71	8.21	2.2E-13	Diastolic blood pressure	
GBM	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	0.76	9.01	2.8E-15	Diastolic blood pressure	
GBM	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.39	5.39	3.34E-7	Common traits (Other)	
GBM	cis	1	rs17126640	chr12:52704991	SPRYD3	chr12:53458398-53473138:-	0.6	4.21	4.9E-5	Plasma amyloid beta peptide concentrations (ABx-42)	
GBM	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.72	-8.4	7.82E-14	Diastolic blood pressure	
GBM	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.69	-7.65	4.45E-12	Diastolic blood pressure	
GBM	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.74	-8.65	1.98E-14	Diastolic blood pressure	
GBM	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.76	-8.97	3.53E-15	Diastolic blood pressure	
GBM	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-0.73	-8.6	2.65E-14	Diastolic blood pressure	
GBM	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.72	-8.4	7.82E-14	Diastolic blood pressure	
GBM	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.71	-8.35	1.04E-13	Diastolic blood pressure	
GBM	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.75	8.78	9.65E-15	Diastolic blood pressure	
GBM	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.75	8.78	9.65E-15	Diastolic blood pressure	
GBM	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.75	8.78	9.65E-15	Diastolic blood pressure	
GBM	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-0.71	-8.35	1.04E-13	Diastolic blood pressure	
GBM	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.74	8.81	8.59E-15	Diastolic blood pressure	
GBM	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.71	-8.35	1.04E-13	Diastolic blood pressure	
GBM	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-0.71	-8.35	1.04E-13	Diastolic blood pressure	
GBM	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-0.73	-8.56	3.36E-14	Diastolic blood pressure	
GBM	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-0.79	-9.28	6.19E-16	Diastolic blood pressure	
GBM	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-0.73	-8.6	2.65E-14	Diastolic blood pressure	
GBM	cis	1	rs1716984	chr3:41965532	ULK4	chr3:41288091-42003660:-	-0.75	-8.73	1.31E-14	Diastolic blood pressure	
GBM	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.69	-7.72	3.16E-12	Diastolic blood pressure	
GBM	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.69	-7.72	3.16E-12	Diastolic blood pressure	
GBM	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-0.71	-8.35	1.04E-13	Diastolic blood pressure	
GBM	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-0.73	-8.6	2.65E-14	Diastolic blood pressure	
GBM	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-0.73	-8.6	2.65E-14	Diastolic blood pressure	
GBM	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.71	-8.35	1.04E-13	Diastolic blood pressure	
GBM	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.78	9.27	6.65E-16	Diastolic blood pressure	
GBM	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.73	-8.6	2.65E-14	Diastolic blood pressure	
GBM	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.72	-8.4	7.82E-14	Diastolic blood pressure	
GBM	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.76	8.97	3.53E-15	Diastolic blood pressure	
GBM	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.76	8.97	3.53E-15	Diastolic blood pressure	
GBM	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.71	8.29	1.43E-13	Diastolic blood pressure	
GBM	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-0.75	-8.82	8.04E-15	Diastolic blood pressure	
GBM	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-0.68	-8.19	2.46E-13	Diastolic blood pressure	
GBM	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-0.77	-9	2.93E-15	Diastolic blood pressure	
GBM	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.75	8.78	9.65E-15	Diastolic blood pressure	
GBM	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.77	9.05	2.17E-15	Diastolic blood pressure	
GBM	cis	1	rs17223420	chr12:983720	RAD52	chr12:1021255-1099219:-	-0.5	-4.95	2.34E-6	Colorectal cancer	
GBM	cis	1	rs17277546	chr7:99489571	ZNF789	chr7:99070515-99085217:+	0.61	4.66	8.06E-6	Dehydroepiandrosterone sulphate levels;Metabolic traits	
GBM	cis	1	rs17290219	chr3:150881774	CLRN1OS	chr3:150570271-150797617:+	-0.74	-4.56	1.2E-5	Heschl's gyrus morphology	
GBM	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.74	11.68	8.48E-22	Carotid intima media thickness	
GBM	cis	1	rs17450788	chr19:22224755	ZNF257	chr19:22235266-22273901:+	0.68	4.81	4.18E-6	Body mass index (change over time)	
GBM	cis	1	rs17549954	chr17:61707032	FTSJ3	chr17:61896795-61905031:-	0.45	4.86	3.38E-6	Body mass index	
GBM	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.48	-5.61	1.23E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.45	5.35	3.99E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.49	-5.68	8.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.49	-5.68	8.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.48	-5.69	8.51E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.49	-5.68	8.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.47	-5.21	7.38E-7	Forced vital capacity	
GBM	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.43	-5.27	5.68E-7	Temperament	
GBM	cis	1	rs17671194	chr15:40667539	C15orf23	chr15:40674922-40686488:+	0.74	5.26	5.91E-7	Heschl's gyrus morphology	
GBM	cis	1	rs17694493	chr9:22041998	CDKN2A	chr9:21967752-21994490:-	0.67	6.34	3.8E-9	Prostate cancer	
GBM	cis	1	rs17694493	chr9:22041998	CDKN2BAS	chr9:21994790-22121091:+	0.58	5.19	8.17E-7	Prostate cancer	
GBM	cis	1	rs17694493	chr9:22041998	CDKN2B	chr9:22002906-22009312:-	0.56	4.91	2.76E-6	Prostate cancer	
GBM	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.38	4.94	2.48E-6	Esophageal cancer (squamous cell)	
GBM	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.35	-4.6	1.02E-5	Esophageal cancer (squamous cell)	
GBM	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.36	-4.82	4.08E-6	Esophageal cancer (squamous cell)	
GBM	cis	1	rs17839567	chr16:31057945	MYST1	chr16:31128985-31142713:+	0.38	4.49	1.57E-5	Response to metformin (IC50)	
GBM	cis	1	rs1806263	chr17:5317492	NUP88	chr17:5264268-5322996:-	0.33	4.17	5.69E-5	Body mass index	
GBM	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.54	-5.46	2.39E-7	IgG glycosylation	
GBM	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.92	10.09	6.67E-18	Type 2 diabetes	
GBM	cis	1	rs183618	chr17:53235974	COX11	chr17:53029259-53046064:-	0.34	4.47	1.7E-5	Menarche (age at onset)	
GBM	cis	1	rs1849004	chr19:22142455	ZNF257	chr19:22235266-22273901:+	0.68	4.73	5.99E-6	Body mass index (change over time)	
GBM	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.47	-5.47	2.35E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.66	-8.57	3.18E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.92	10.09	6.67E-18	Type 2 diabetes	
GBM	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.57	4.51	1.48E-5	Multiple sclerosis	
GBM	cis	1	rs1877316	chr17:61766880	FTSJ3	chr17:61896795-61905031:-	0.44	4.88	3.11E-6	Body mass index	
GBM	cis	1	rs1882099	chr4:1352685	CRIPAK	chr4:1385340-1389782:+	0.4	4.77	4.92E-6	Systolic blood pressure	
GBM	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.38	-4.99	2.0E-6	Esophageal cancer (squamous cell)	
GBM	cis	1	rs1886682	chr1:92977275	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs1886683	chr1:92976023	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs1888997	chr20:25298988	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs1888998	chr20:25291826	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs1888999	chr20:25291848	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs1904295	chr10:64982876	NRBF2	chr10:64893007-64914785:+	-0.62	-5.49	2.08E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.65	-8.25	1.84E-13	Response to antipsychotic treatment	
GBM	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.63	-5.69	8.42E-8	Rheumatoid arthritis	
GBM	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.67	-8.66	1.92E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.94	-4.95	2.35E-6	Schizophrenia	
GBM	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.77	7.97	8.15E-13	Diastolic blood pressure	
GBM	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.68	-8.76	1.1E-14	Response to antipsychotic treatment	
GBM	cis	1	rs2000999	chr16:72108093	HPR	chr16:72097125-72111144:+	1.09	10.13	5.23E-18	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.42	-4.4	2.26E-5	Forced vital capacity	
GBM	cis	1	rs2013288	chr17:61785904	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs2017091	chr15:79032744	ADAMTS7	chr15:79051546-79103773:-	0.33	4.19	5.15E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.74	-6.24	6.22E-9	Rheumatoid arthritis	
GBM	cis	1	rs2027003	chr20:25350498	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2027004	chr20:25350618	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.74	-6.05	1.51E-8	Type 2 diabetes	
GBM	cis	1	rs2031494	chr1:92965969	EVI5	chr1:92974255-93257961:-	-0.55	-4.95	2.3E-6	Cholesterol, total	
GBM	cis	1	rs2031532	chr13:50080847	SETDB2	chr13:50018429-50069138:+	0.33	4.28	3.6E-5	Cardiac hypertrophy	
GBM	cis	1	rs2032843	chr17:46847524	SNX11	chr17:46184911-46200105:+	0.34	4.39	2.34E-5	Schizophrenia or bipolar disorder	
GBM	cis	1	rs2032844	chr17:46847364	SNX11	chr17:46184911-46200105:+	0.33	4.29	3.59E-5	Schizophrenia or bipolar disorder	
GBM	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.38	5.01	1.81E-6	Longevity	
GBM	cis	1	rs2055232	chr17:8614880	ALOX12B	chr17:7975954-7991021:-	-0.52	-4.2	4.92E-5	Heroin dependence	
GBM	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.49	5.57	1.5E-7	Pancreatic cancer	
GBM	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.4	5.5	2.03E-7	Common traits (Other)	
GBM	cis	1	rs2074038	chr11:44087989	ACCS	chr11:44087475-44105569:+	0.82	7.56	7.23E-12	IgA nephropathy	
GBM	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.43	-5.48	2.27E-7	Homocysteine levels	
GBM	cis	1	rs2081302	chr2:23945355	LOC375190	chr2:24299728-24397519:+	0.35	4.22	4.63E-5	Obesity-related traits	
GBM	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.47	-5.47	2.35E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs2092990	chr20:3346338	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.94	10.41	1.11E-18	Type 2 diabetes	
GBM	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs2113422	chr2:23939007	LOC375190	chr2:24299728-24397519:+	0.34	4.21	4.88E-5	Obesity-related traits	
GBM	cis	1	rs2113423	chr2:23942287	LOC375190	chr2:24299728-24397519:+	0.34	4.19	5.29E-5	Obesity-related traits	
GBM	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.75	8.51	4.27E-14	Diastolic blood pressure	
GBM	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.4	-6.36	3.38E-9	Kawasaki disease	
GBM	cis	1	rs2143346	chr6:26198449	HIST1H3E	chr6:26224427-26226589:+	-0.85	-5.68	8.94E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs2143347	chr6:26198494	HIST1H3E	chr6:26224427-26226589:+	0.85	5.68	8.94E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.33	-4.18	5.49E-5	Eye color traits	
GBM	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.68	-8.18	2.66E-13	Response to antipsychotic treatment	
GBM	cis	1	rs2172252	chr3:49678307	LAMB2L	chr3:49190293-49191834:-	0.51	4.83	3.85E-6	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs2184000	chr20:25395878	FAM182A	chr20:26035250-26067552:+	0.65	6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.76	-8.43	6.86E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs2236087	chr20:3255905	ITPA	chr20:3190056-3204504:+	-0.52	-5.27	5.82E-7	IFN-related cytopenia	
GBM	cis	1	rs2236089	chr20:3257194	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2236092	chr20:3258188	ITPA	chr20:3190056-3204504:+	-0.47	-4.72	6.14E-6	IFN-related cytopenia	
GBM	cis	1	rs2236098	chr20:3267133	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2236104	chr20:3277602	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2236106	chr20:3278410	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2236107	chr20:3285821	ITPA	chr20:3190056-3204504:+	-0.55	-5.39	3.32E-7	IFN-related cytopenia	
GBM	cis	1	rs2236108	chr20:3286331	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2236117	chr20:3302021	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2236118	chr20:3302058	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2236122	chr20:3305240	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2236123	chr20:3305305	ITPA	chr20:3190056-3204504:+	0.52	5.21	7.33E-7	IFN-related cytopenia	
GBM	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.39	5.39	3.34E-7	Common traits (Other)	
GBM	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.43	5.76	6.18E-8	Longevity	
GBM	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.59	7.09	8.48E-11	Longevity	
GBM	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.59	7.09	8.48E-11	Longevity	
GBM	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.59	7.09	8.48E-11	Longevity	
GBM	cis	1	rs224329	chr20:34019579	CPNE1	chr20:34213968-34262539:-	-0.54	-5.27	5.66E-7	Height	
GBM	cis	1	rs2248393	chr20:33926103	CPNE1	chr20:34213968-34262539:-	-0.57	-5.66	9.57E-8	Height	
GBM	cis	1	rs2248393	chr20:33926103	UQCC	chr20:33890383-33999833:-	-0.45	-4.34	2.91E-5	Height	
GBM	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.66	-4.45	1.89E-5	Tumor biomarkers	
GBM	cis	1	rs2257420	chr20:25275890	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2257432	chr20:25271086	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2257496	chr20:25279315	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2257808	chr20:25266450	FAM182A	chr20:26035250-26067552:+	-0.68	-6.75	4.75E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2257809	chr20:25266476	FAM182A	chr20:26035250-26067552:+	-0.68	-6.75	4.75E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2257982	chr20:25269630	FAM182A	chr20:26035250-26067552:+	-0.66	-6.5	1.72E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2257985	chr20:25269743	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2257988	chr20:25270003	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2257991	chr20:25270339	FAM182A	chr20:26035250-26067552:+	0.7	6.94	1.82E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2258066	chr20:25271326	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2258135	chr20:25272323	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2258201	chr20:25272490	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2258563	chr20:25273435	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2258617	chr20:25274318	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2258719	chr20:25275843	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2258769	chr20:25276680	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2258879	chr20:25279213	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2258884	chr20:25279539	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2259837	chr20:25280205	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2259873	chr20:25280781	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2259926	chr20:25281733	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2259928	chr20:25281834	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2259956	chr20:25282433	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2260160	chr15:43895643	ADAL	chr15:43622872-43646094:+	-0.72	-4.8	4.34E-6	Tumor biomarkers	
GBM	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.38	4.98	2.06E-6	Height	
GBM	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-0.79	-9.28	6.19E-16	Diastolic blood pressure	
GBM	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.79	-9.06	2.15E-15	Diastolic blood pressure	
GBM	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.84	-6.33	3.95E-9	Rheumatoid arthritis	
GBM	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.58	7.07	9.4E-11	Longevity	
GBM	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.8	-7.63	4.92E-12	Cholesterol, total	
GBM	cis	1	rs2277869	chr12:1016910	RAD52	chr12:1021255-1099219:-	-0.51	-4.86	3.45E-6	Colorectal cancer	
GBM	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.42	-5.74	6.78E-8	Longevity	
GBM	cis	1	rs2281494	chr20:3235494	ITPA	chr20:3190056-3204504:+	-0.46	-4.71	6.33E-6	IFN-related cytopenia	
GBM	cis	1	rs2281497	chr20:3258874	ITPA	chr20:3190056-3204504:+	-0.47	-4.72	6.14E-6	IFN-related cytopenia	
GBM	cis	1	rs2281500	chr20:3262824	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2281503	chr20:3263636	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs2281808	chr20:1610551	SIRPB1	chr20:1545030-1600689:-	0.36	4.19	5.23E-5	Type 1 diabetes	
GBM	cis	1	rs2285946	chr7:21583329	DNAH11	chr7:21582833-21941455:+	-0.58	-6.33	4.03E-9	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
GBM	cis	1	rs2285947	chr7:21584088	DNAH11	chr7:21582833-21941455:+	0.59	6.4	2.75E-9	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
GBM	cis	1	rs2285949	chr7:21584243	DNAH11	chr7:21582833-21941455:+	-0.59	-6.4	2.78E-9	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
GBM	cis	1	rs2285950	chr7:21584432	DNAH11	chr7:21582833-21941455:+	0.58	6.03	1.67E-8	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
GBM	cis	1	rs2287679	chr19:33600764	GPATCH1	chr19:33571786-33621318:+	0.4	4.5	1.54E-5	Bone properties (heel)	
GBM	cis	1	rs2287679	chr19:33600764	RHPN2	chr19:33469499-33555824:-	-0.38	-4.24	4.27E-5	Bone properties (heel)	
GBM	cis	1	rs2287680	chr19:33608566	GPATCH1	chr19:33571786-33621318:+	-0.41	-4.57	1.16E-5	Bone properties (heel)	
GBM	cis	1	rs2287680	chr19:33608566	RHPN2	chr19:33469499-33555824:-	0.39	4.29	3.47E-5	Bone properties (heel)	
GBM	cis	1	rs2287997	chr16:72140553	HPR	chr16:72097125-72111144:+	1.15	10.63	3.08E-19	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.44	-5.85	4.0E-8	Longevity	
GBM	cis	1	rs2291542	chr3:49751585	RBM6	chr3:49977592-50137484:+	-0.34	-4.83	3.85E-6	Resting heart rate	
GBM	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.74	8.62	2.33E-14	Cognitive function	
GBM	cis	1	rs2294008	chr8:143761931	PSCA	chr8:143761875-143764142:+	0.55	4.87	3.24E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2294010	chr8:143762430	PSCA	chr8:143761875-143764142:+	0.56	5	1.89E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2295770	chr10:102239829	TLX1	chr10:102891061-102897545:+	0.45	4.19	5.18E-5	Palmitoleic acid (16:1n-7) plasma levels	
GBM	cis	1	rs2297496	chr20:25295787	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2297497	chr20:25297909	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.59	4.39	2.36E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.59	4.56	1.19E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs2307021	chr3:49765483	RBM6	chr3:49977592-50137484:+	-0.35	-4.94	2.43E-6	Resting heart rate	
GBM	cis	1	rs231519	chr17:41961051	MPP3	chr17:41878169-41910538:-	0.45	4.17	5.55E-5	Cognitive function	
GBM	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.66	-8.58	2.89E-14	Response to antipsychotic treatment	
GBM	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.79	-6.51	1.61E-9	Type 2 diabetes	
GBM	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.77	-6.34	3.71E-9	Type 2 diabetes	
GBM	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.42	-5.42	2.92E-7	Homocysteine levels	
GBM	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.43	-5.42	2.93E-7	Homocysteine levels	
GBM	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.39	-5.19	8.11E-7	Common traits (Other)	
GBM	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.39	-5.14	1.02E-6	Common traits (Other)	
GBM	cis	1	rs2359811	chr19:22152876	ZNF257	chr19:22235266-22273901:+	0.64	4.54	1.28E-5	Body mass index (change over time)	
GBM	cis	1	rs2359820	chr19:22208114	ZNF257	chr19:22235266-22273901:+	0.66	4.47	1.69E-5	Body mass index (change over time)	
GBM	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.38	-5.06	1.47E-6	Longevity	
GBM	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.37	4.81	4.15E-6	Longevity	
GBM	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.72	-4.96	2.24E-6	Plasma clusterin levels	
GBM	cis	1	rs2371623	chr3:41761083	ULK4	chr3:41288091-42003660:-	0.79	8.39	8.44E-14	Diastolic blood pressure	
GBM	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	0.76	8.72	1.37E-14	Diastolic blood pressure	
GBM	cis	1	rs2387880	chr20:25377787	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2387881	chr20:25378172	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2387884	chr20:25379069	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2391159	chr1:92971951	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs2391160	chr1:92992797	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs2393980	chr10:65224510	JMJD1C	chr10:64926990-65225722:-	0.41	4.19	5.12E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs2393980	chr10:65224510	NRBF2	chr10:64893007-64914785:+	0.61	5.64	1.08E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs2395400	chr6:33770076	LEMD2	chr6:33738991-33756906:-	0.41	4.81	4.31E-6	Body mass index	
GBM	cis	1	rs2424700	chr20:25266513	FAM182A	chr20:26035250-26067552:+	-0.67	-6.69	6.67E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2424704	chr20:25273929	FAM182A	chr20:26035250-26067552:+	-0.69	-6.85	2.99E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2424710	chr20:25283886	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2424712	chr20:25416942	FAM182A	chr20:26035250-26067552:+	-0.65	-6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2424713	chr20:25418482	FAM182A	chr20:26035250-26067552:+	-0.66	-6.59	1.11E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2424716	chr20:25423538	FAM182A	chr20:26035250-26067552:+	-0.66	-6.66	7.73E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2425065	chr20:33926268	CPNE1	chr20:34213968-34262539:-	-0.55	-5.4	3.17E-7	Height	
GBM	cis	1	rs2425065	chr20:33926268	UQCC	chr20:33890383-33999833:-	-0.44	-4.23	4.53E-5	Height	
GBM	cis	1	rs2425066	chr20:33927006	CPNE1	chr20:34213968-34262539:-	-0.55	-5.4	3.17E-7	Height	
GBM	cis	1	rs2425066	chr20:33927006	UQCC	chr20:33890383-33999833:-	-0.44	-4.23	4.53E-5	Height	
GBM	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.93	10.25	2.63E-18	Type 2 diabetes	
GBM	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.74	5.31	4.69E-7	Tumor biomarkers	
GBM	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.65	-4.24	4.22E-5	Tumor biomarkers	
GBM	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.71	-4.8	4.37E-6	Tumor biomarkers	
GBM	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.59	-7.5	9.93E-12	Ankylosing spondylitis	
GBM	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.5	4.88	3.12E-6	Ankylosing spondylitis	
GBM	cis	1	rs2466128	chr10:65208321	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.7	4.77	5.02E-6	Tumor biomarkers	
GBM	cis	1	rs2474777	chr20:25272633	FAM182A	chr20:26035250-26067552:+	-0.58	-5.95	2.5E-8	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482911	chr20:25395528	FAM182A	chr20:26035250-26067552:+	0.66	6.59	1.11E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482919	chr20:25299756	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482927	chr20:25327151	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482928	chr20:25331530	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482930	chr20:25334115	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482931	chr20:25334445	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482937	chr20:25340786	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482940	chr20:25349830	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482941	chr20:25361216	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2482943	chr20:25380593	FAM182A	chr20:26035250-26067552:+	0.68	6.68	6.81E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2500404	chr20:25359758	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2500405	chr20:25360826	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2500418	chr20:25382268	FAM182A	chr20:26035250-26067552:+	0.67	6.64	8.4E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2500424	chr20:25391969	FAM182A	chr20:26035250-26067552:+	0.66	6.59	1.09E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2500432	chr20:25290512	FAM182A	chr20:26035250-26067552:+	-0.65	-6.5	1.69E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2500436	chr20:25406366	FAM182A	chr20:26035250-26067552:+	0.66	6.59	1.11E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2500443	chr20:25331442	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2500446	chr20:25339664	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2500448	chr20:25404027	FAM182A	chr20:26035250-26067552:+	0.66	6.59	1.1E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	1.01	10.39	1.2E-18	Type 2 diabetes	
GBM	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	1	10.32	1.76E-18	Type 2 diabetes	
GBM	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.93	-10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.93	10.25	2.63E-18	Type 2 diabetes	
GBM	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.94	10.4	1.15E-18	Type 2 diabetes	
GBM	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.94	10.4	1.15E-18	Type 2 diabetes	
GBM	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs2549803	chr5:96174929	ERAP1	chr5:96096515-96149837:-	-0.42	-4.75	5.34E-6	Urate levels (BMI interaction)	
GBM	cis	1	rs2572910	chr8:143770135	LY6K	chr8:143781529-143785582:+	0.46	4.31	3.24E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2572910	chr8:143770135	PSCA	chr8:143761875-143764142:+	0.55	5	1.88E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2585179	chr8:143774193	LY6K	chr8:143781529-143785582:+	0.46	4.31	3.24E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2585179	chr8:143774193	PSCA	chr8:143761875-143764142:+	0.55	5	1.88E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.73	-4.93	2.49E-6	Tumor biomarkers	
GBM	cis	1	rs2616629	chr10:65213816	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs2616630	chr10:65213339	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs2617433	chr5:96176441	ERAP1	chr5:96096515-96149837:-	-0.41	-4.7	6.64E-6	Urate levels (BMI interaction)	
GBM	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.75	8.78	9.65E-15	Diastolic blood pressure	
GBM	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.59	-7.5	1.02E-11	Ankylosing spondylitis	
GBM	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.48	4.69	7.06E-6	Ankylosing spondylitis	
GBM	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.49	-5.68	8.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs2665826	chr17:61944924	FTSJ3	chr17:61896795-61905031:-	0.49	5.58	1.43E-7	Body mass index	
GBM	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.77	9.05	2.17E-15	Diastolic blood pressure	
GBM	cis	1	rs2683696	chr3:41914898	ULK4	chr3:41288091-42003660:-	0.77	9.13	1.41E-15	Diastolic blood pressure	
GBM	cis	1	rs2717562	chr8:143776668	LY6K	chr8:143781529-143785582:+	0.46	4.31	3.24E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2717562	chr8:143776668	PSCA	chr8:143761875-143764142:+	0.55	5	1.88E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2719815	chr10:65210294	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.56	-7.17	5.73E-11	Ankylosing spondylitis	
GBM	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.5	4.99	1.97E-6	Ankylosing spondylitis	
GBM	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.59	7.5	1.02E-11	Ankylosing spondylitis	
GBM	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.48	-4.69	7.06E-6	Ankylosing spondylitis	
GBM	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.47	-5.39	3.34E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.47	-5.39	3.34E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.65	-8.25	1.84E-13	Response to antipsychotic treatment	
GBM	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.68	-8.5	4.56E-14	Response to antipsychotic treatment	
GBM	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.67	-8.51	4.43E-14	Response to antipsychotic treatment	
GBM	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.33	-4.18	5.49E-5	Eye color traits	
GBM	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.33	-4.18	5.49E-5	Eye color traits	
GBM	cis	1	rs2838009	chr21:42694284	FAM3B	chr21:42676177-42729654:+	-0.41	-4.26	3.91E-5	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
GBM	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.46	-4.56	1.17E-5	Testicular germ cell tumor	
GBM	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.44	-4.29	3.46E-5	Testicular germ cell tumor	
GBM	cis	1	rs2839440	chr21:43443498	TMPRSS2	chr21:42836479-42903043:-	0.6	4.19	5.15E-5	Preeclampsia	
GBM	cis	1	rs28463311	chr17:61919643	FTSJ3	chr17:61896795-61905031:-	0.48	5.44	2.71E-7	Body mass index	
GBM	cis	1	rs28512382	chr10:1092195	IDI2	chr10:1064847-1071799:-	-0.49	-4.79	4.61E-6	Response to angiotensin II receptor blocker therapy	
GBM	cis	1	rs2854218	chr17:61942940	FTSJ3	chr17:61896795-61905031:-	0.44	4.86	3.42E-6	Body mass index	
GBM	cis	1	rs2854219	chr17:61942682	FTSJ3	chr17:61896795-61905031:-	0.48	5.45	2.52E-7	Body mass index	
GBM	cis	1	rs2854223	chr17:61939014	FTSJ3	chr17:61896795-61905031:-	0.46	5.39	3.31E-7	Body mass index	
GBM	cis	1	rs2856	chr20:25433536	FAM182A	chr20:26035250-26067552:+	-0.65	-6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.41	4.22	4.63E-5	Forced vital capacity	
GBM	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.42	4.29	3.54E-5	Forced vital capacity	
GBM	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.77	7.97	8.15E-13	Diastolic blood pressure	
GBM	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs2874121	chr17:61731024	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.79	7.82	1.81E-12	Diastolic blood pressure	
GBM	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.4	-5.34	4.13E-7	Longevity	
GBM	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.39	5.19	8.31E-7	Longevity	
GBM	cis	1	rs2893922	chr10:65247019	NRBF2	chr10:64893007-64914785:+	-0.61	-5.86	3.71E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs2911130	chr5:96183427	ERAP1	chr5:96096515-96149837:-	-0.4	-4.6	1.03E-5	Urate levels (BMI interaction)	
GBM	cis	1	rs2911131	chr5:96185949	ERAP1	chr5:96096515-96149837:-	0.4	4.51	1.45E-5	Urate levels (BMI interaction)	
GBM	cis	1	rs2911132	chr5:96186988	ERAP1	chr5:96096515-96149837:-	-0.4	-4.58	1.09E-5	Urate levels (BMI interaction)	
GBM	cis	1	rs2911140	chr5:96179943	ERAP1	chr5:96096515-96149837:-	-0.41	-4.68	7.31E-6	Urate levels (BMI interaction)	
GBM	cis	1	rs2920282	chr8:143757763	PSCA	chr8:143761875-143764142:+	0.55	4.84	3.71E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2920292	chr8:143765699	PSCA	chr8:143761875-143764142:+	0.56	5.01	1.83E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2920293	chr8:143765414	PSCA	chr8:143761875-143764142:+	0.56	5	1.87E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2920294	chr8:143765326	PSCA	chr8:143761875-143764142:+	0.56	5.01	1.83E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2920295	chr8:143764937	LY6K	chr8:143781529-143785582:+	0.46	4.25	4.18E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2920295	chr8:143764937	PSCA	chr8:143761875-143764142:+	0.55	4.88	3.09E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2920296	chr8:143763109	PSCA	chr8:143761875-143764142:+	0.56	5	1.89E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2920297	chr8:143763083	PSCA	chr8:143761875-143764142:+	0.56	5	1.89E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2920298	chr8:143763043	PSCA	chr8:143761875-143764142:+	0.56	5	1.89E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.71	-4.73	5.89E-6	Tumor biomarkers	
GBM	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.71	-4.8	4.37E-6	Tumor biomarkers	
GBM	cis	1	rs2976388	chr8:143760256	LY6K	chr8:143781529-143785582:+	0.51	4.52	1.43E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2976388	chr8:143760256	PSCA	chr8:143761875-143764142:+	0.63	5.44	2.72E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2976392	chr8:143762932	PSCA	chr8:143761875-143764142:+	0.56	5	1.89E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2976394	chr8:143763622	PSCA	chr8:143761875-143764142:+	0.56	5	1.85E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2976396	chr8:143764001	PSCA	chr8:143761875-143764142:+	-0.51	-4.52	1.43E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2976398	chr8:143764879	PSCA	chr8:143761875-143764142:+	0.56	5.01	1.83E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2978982	chr8:143763490	PSCA	chr8:143761875-143764142:+	0.56	5	1.89E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
GBM	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.43	-5.48	2.27E-7	Homocysteine levels	
GBM	cis	1	rs3002702	chr20:25268920	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.59	-7.5	9.93E-12	Ankylosing spondylitis	
GBM	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.5	4.88	3.12E-6	Ankylosing spondylitis	
GBM	cis	1	rs3026101	chr17:5280440	NUP88	chr17:5264268-5322996:-	-0.34	-4.33	2.96E-5	Body mass index	
GBM	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.59	-7.33	2.42E-11	Ankylosing spondylitis	
GBM	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.53	5.11	1.17E-6	Ankylosing spondylitis	
GBM	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.6	-7.61	5.72E-12	Ankylosing spondylitis	
GBM	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.5	4.83	3.83E-6	Ankylosing spondylitis	
GBM	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.6	-7.61	5.72E-12	Ankylosing spondylitis	
GBM	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.5	4.83	3.83E-6	Ankylosing spondylitis	
GBM	cis	1	rs3091242	chr1:25674785	RHD	chr1:25598981-25656935:+	-0.73	-8.35	1.07E-13	Erythrocyte sedimentation rate	
GBM	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.47	-5.39	3.34E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.72	-4.8	4.39E-6	Tumor biomarkers	
GBM	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.49	-5.68	8.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.47	-5.5	2.02E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs3197999	chr3:49721532	LAMB2L	chr3:49190293-49191834:-	0.5	4.58	1.1E-5	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.57	-5.29	5.29E-7	Dental caries	
GBM	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.76	-8.4	7.89E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.41	-5.48	2.25E-7	Longevity	
GBM	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.67	6.66	7.78E-10	Renal underexcretion gout;Gout	
GBM	cis	1	rs3310	chr20:3237232	ITPA	chr20:3190056-3204504:+	-0.47	-4.72	6.14E-6	IFN-related cytopenia	
GBM	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.94	10.4	1.15E-18	Type 2 diabetes	
GBM	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs34088794	chr15:40665420	C15orf23	chr15:40674922-40686488:+	0.74	5.28	5.45E-7	Heschl's gyrus morphology	
GBM	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.66	-8.44	6.23E-14	Response to antipsychotic treatment	
GBM	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.67	-8.62	2.43E-14	Response to antipsychotic treatment	
GBM	cis	1	rs34285886	chr12:57302520	ESYT1	chr12:56522054-56538452:+	-0.48	-4.3	3.35E-5	Airway wall thickness	
GBM	cis	1	rs34344888	chr14:23387585	HAUS4	chr14:23415438-23426335:-	-0.38	-5.02	1.71E-6	Educational attainment (years of education)	
GBM	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.67	-8.62	2.43E-14	Response to antipsychotic treatment	
GBM	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs34645895	chr20:25368373	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs34762726	chr3:49689210	LAMB2L	chr3:49190293-49191834:-	0.52	4.95	2.28E-6	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.59	4.56	1.19E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.66	-8.54	3.73E-14	Response to antipsychotic treatment	
GBM	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.47	5.4	3.15E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.48	-5.28	5.44E-7	Forced vital capacity	
GBM	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.67	-8.6	2.61E-14	Response to antipsychotic treatment	
GBM	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.67	-8.62	2.43E-14	Response to antipsychotic treatment	
GBM	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.68	8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs35468353	chr16:31056433	MYST1	chr16:31128985-31142713:+	0.38	4.47	1.71E-5	Response to metformin (IC50)	
GBM	cis	1	rs35608327	chr15:90369204	AP3S2	chr15:90373832-90456222:-	-0.67	-5.94	2.59E-8	Type 2 diabetes	
GBM	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.67	-8.6	2.61E-14	Response to antipsychotic treatment	
GBM	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.65	-8.21	2.26E-13	Response to antipsychotic treatment	
GBM	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.68	-8.58	2.9E-14	Response to antipsychotic treatment	
GBM	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs3734530	chr6:26195408	HIST1H3E	chr6:26224427-26226589:+	0.85	5.67	9.22E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.49	5.47	2.32E-7	Pancreatic cancer	
GBM	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.65	6.23	6.29E-9	Schizophrenia	
GBM	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.59	4.56	1.19E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs3749237	chr3:49770032	RBM6	chr3:49977592-50137484:+	-0.36	-5.07	1.36E-6	Resting heart rate	
GBM	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.43	5.24	6.55E-7	Fractional exhaled nitric oxide (childhood)	
GBM	cis	1	rs3757135	chr6:26200707	HIST1H3E	chr6:26224427-26226589:+	0.86	5.72	7.24E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs3760891	chr19:33599708	GPATCH1	chr19:33571786-33621318:+	0.4	4.5	1.54E-5	Bone properties (heel)	
GBM	cis	1	rs3760891	chr19:33599708	RHPN2	chr19:33469499-33555824:-	-0.38	-4.24	4.27E-5	Bone properties (heel)	
GBM	cis	1	rs3761117	chr20:25388070	FAM182A	chr20:26035250-26067552:+	0.67	6.62	9.52E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs3770752	chr2:37576136	CEBPZ	chr2:37428778-37458740:-	0.37	4.65	8.34E-6	Schizophrenia	
GBM	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.76	7.96	8.67E-13	Diastolic blood pressure	
GBM	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.42	-5.74	6.78E-8	Longevity	
GBM	cis	1	rs3786933	chr19:33602881	GPATCH1	chr19:33571786-33621318:+	0.4	4.5	1.54E-5	Bone properties (heel)	
GBM	cis	1	rs3786933	chr19:33602881	RHPN2	chr19:33469499-33555824:-	-0.38	-4.24	4.27E-5	Bone properties (heel)	
GBM	cis	1	rs3793772	chr10:102222825	TLX1	chr10:102891061-102897545:+	0.41	4.15	6.0E-5	Palmitoleic acid (16:1n-7) plasma levels	
GBM	cis	1	rs3794695	chr16:72097827	HPR	chr16:72097125-72111144:+	1.08	10	1.1E-17	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.55	-4.31	3.3E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.38	-5.88	3.42E-8	Kawasaki disease	
GBM	cis	1	rs3817181	chr17:61776538	FTSJ3	chr17:61896795-61905031:-	0.44	4.83	3.85E-6	Body mass index	
GBM	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.57	4.51	1.48E-5	Multiple sclerosis	
GBM	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.76	8.43	6.86E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.53	-4.28	3.6E-5	Abdominal aortic aneurysm	
GBM	cis	1	rs3890604	chr3:41760625	ULK4	chr3:41288091-42003660:-	0.79	8.39	8.44E-14	Diastolic blood pressure	
GBM	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.49	-5.7	7.97E-8	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs3931020	chr1:75235317	CRYZ	chr1:75171175-75199092:-	-0.54	-7.32	2.58E-11	Resistin levels	
GBM	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.69	-7.72	3.16E-12	Diastolic blood pressure	
GBM	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.68	8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.79	-6.51	1.61E-9	Type 2 diabetes	
GBM	cis	1	rs397119	chr20:25440187	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs398036	chr20:25439850	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.58	-7.11	7.86E-11	Inflammatory skin disease	
GBM	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.52	4.94	2.45E-6	Inflammatory skin disease	
GBM	cis	1	rs401166	chr20:25446308	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs404394	chr20:25447896	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.68	-8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.68	-8.29	1.45E-13	Eye color traits	
GBM	cis	1	rs41266807	chr6:26199822	HIST1H3E	chr6:26224427-26226589:+	0.81	5.46	2.4E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs4133250	chr10:65092405	ADO	chr10:64564516-64568238:+	-0.49	-4.3	3.39E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4133250	chr10:65092405	NRBF2	chr10:64893007-64914785:+	-0.66	-5.79	5.37E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4149420	chr2:108913090	SULT1C2	chr2:108905095-108926370:+	0.62	6.23	6.47E-9	Lobe size	
GBM	cis	1	rs4149423	chr2:108916044	SULT1C2	chr2:108905095-108926370:+	0.63	6.12	1.07E-8	Lobe size	
GBM	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.48	5.42	2.9E-7	Pancreatic cancer	
GBM	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.48	5.36	3.84E-7	Pancreatic cancer	
GBM	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.48	5.48	2.25E-7	Pancreatic cancer	
GBM	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.49	5.47	2.32E-7	Pancreatic cancer	
GBM	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.49	5.47	2.28E-7	Pancreatic cancer	
GBM	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.48	-5.36	3.77E-7	Pancreatic cancer	
GBM	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.48	5.46	2.44E-7	Pancreatic cancer	
GBM	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.49	5.47	2.28E-7	Pancreatic cancer	
GBM	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.48	-5.36	3.77E-7	Pancreatic cancer	
GBM	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.47	5.35	3.95E-7	Pancreatic cancer	
GBM	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.49	5.47	2.28E-7	Pancreatic cancer	
GBM	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.48	5.36	3.77E-7	Pancreatic cancer	
GBM	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.47	5.19	8.06E-7	Pancreatic cancer	
GBM	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.43	-4.64	8.69E-6	Pancreatic cancer	
GBM	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.49	5.58	1.42E-7	Pancreatic cancer	
GBM	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.47	5.25	6.39E-7	Pancreatic cancer	
GBM	cis	1	rs422424	chr20:25445446	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs422844	chr20:25445591	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.42	4.3	3.4E-5	Forced vital capacity	
GBM	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.58	-7	1.33E-10	Longevity	
GBM	cis	1	rs4283605	chr3:49678651	LAMB2L	chr3:49190293-49191834:-	0.51	4.83	3.85E-6	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.5	4.21	4.81E-5	Paget's disease	
GBM	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.63	-5.68	8.96E-8	Rheumatoid arthritis	
GBM	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.49	5.57	1.5E-7	Pancreatic cancer	
GBM	cis	1	rs4375281	chr1:92987575	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.47	5.42	2.9E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs4408846	chr3:41753679	ULK4	chr3:41288091-42003660:-	0.82	8.23	1.99E-13	Diastolic blood pressure	
GBM	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.47	-5.35	4.05E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs4466712	chr10:64933268	NRBF2	chr10:64893007-64914785:+	0.58	5.07	1.41E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4469774	chr10:65309777	NRBF2	chr10:64893007-64914785:+	0.68	6.15	9.67E-9	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs447722	chr20:25443510	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs448396	chr20:25440269	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.44	-5.83	4.31E-8	Longevity	
GBM	cis	1	rs449043	chr21:42700410	FAM3B	chr21:42676177-42729654:+	-0.45	-4.56	1.21E-5	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
GBM	cis	1	rs453329	chr20:25440593	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4553671	chr17:46848272	SNX11	chr17:46184911-46200105:+	0.36	4.63	8.9E-6	Schizophrenia or bipolar disorder	
GBM	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.51	5.1	1.23E-6	Hematology traits	
GBM	cis	1	rs4604732	chr1:247623872	LOC148824	chr1:247687982-247694106:-	0.53	4.35	2.82E-5	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
GBM	cis	1	rs4605213	chr17:49244747	NME1-NME2	chr17:49230920-49249104:+	0.37	4.16	5.79E-5	Height	
GBM	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.43	5.48	2.27E-7	Homocysteine levels	
GBM	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.47	-5.84	4.22E-8	Homocysteine levels	
GBM	cis	1	rs4665238	chr2:23942446	LOC375190	chr2:24299728-24397519:+	0.34	4.19	5.29E-5	Obesity-related traits	
GBM	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.6	-7.61	5.72E-12	Ankylosing spondylitis	
GBM	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.5	4.83	3.83E-6	Ankylosing spondylitis	
GBM	cis	1	rs4704825	chr5:156382308	TIMD4	chr5:156346293-156390266:-	-0.46	-4.91	2.82E-6	Triglycerides;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.67	-8.21	2.27E-13	Response to antipsychotic treatment	
GBM	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.65	-8.25	1.84E-13	Response to antipsychotic treatment	
GBM	cis	1	rs4711346	chr6:33730996	LEMD2	chr6:33738991-33756906:-	0.44	5.25	6.14E-7	Body mass index	
GBM	cis	1	rs4745706	chr10:65159580	NRBF2	chr10:64893007-64914785:+	0.58	5.11	1.15E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4745729	chr10:65277083	NRBF2	chr10:64893007-64914785:+	0.66	5.97	2.26E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4746119	chr10:65129917	NRBF2	chr10:64893007-64914785:+	0.59	5.31	4.82E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4746138	chr10:65241741	JMJD1C	chr10:64926990-65225722:-	0.41	4.19	5.12E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4746138	chr10:65241741	NRBF2	chr10:64893007-64914785:+	0.61	5.64	1.08E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4746149	chr10:65257393	NRBF2	chr10:64893007-64914785:+	-0.72	-5.63	1.11E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4746195	chr10:65307653	NRBF2	chr10:64893007-64914785:+	0.68	6.15	9.67E-9	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4746994	chr10:64905324	NRBF2	chr10:64893007-64914785:+	0.69	5.63	1.13E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4747045	chr10:64926482	NRBF2	chr10:64893007-64914785:+	0.58	5.07	1.41E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.42	-4.25	4.1E-5	Forced vital capacity	
GBM	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.73	-8.38	8.66E-14	Cognitive function	
GBM	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.48	-5.37	3.64E-7	Type 1 diabetes	
GBM	cis	1	rs4768	chr3:49758764	RBM6	chr3:49977592-50137484:+	-0.34	-4.83	3.85E-6	Resting heart rate	
GBM	cis	1	rs4789693	chr17:80421870	PYCR1	chr17:79890269-79895172:-	-0.34	-4.21	4.85E-5	Glucocorticoid-induced osteonecrosis	
GBM	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.55	-4.66	8.02E-6	Alzheimer's disease (cognitive decline)	
GBM	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.77	-8.52	4.1E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.76	-8.27	1.63E-13	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.76	-8.43	6.86E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.77	-8.52	4.1E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.77	-8.52	4.1E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.77	-8.52	4.1E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.64	6.68	6.8E-10	Schizophrenia	
GBM	cis	1	rs4813562	chr20:25352588	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4813563	chr20:25365340	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4813566	chr20:25386465	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815404	chr20:25301845	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815405	chr20:25317492	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815406	chr20:25341316	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815407	chr20:25341478	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815408	chr20:25346678	FAM182A	chr20:26035250-26067552:+	0.69	6.89	2.36E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815409	chr20:25346697	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815411	chr20:25350223	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815412	chr20:25350325	FAM182A	chr20:26035250-26067552:+	-0.66	-6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815417	chr20:25379526	FAM182A	chr20:26035250-26067552:+	0.62	6.09	1.27E-8	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815418	chr20:25382211	FAM182A	chr20:26035250-26067552:+	0.66	6.54	1.4E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815420	chr20:25383979	FAM182A	chr20:26035250-26067552:+	0.64	6.2	7.57E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815421	chr20:25386509	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815424	chr20:25390284	FAM182A	chr20:26035250-26067552:+	0.66	6.66	7.73E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4815426	chr20:25405186	FAM182A	chr20:26035250-26067552:+	0.65	6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs4847181	chr1:93028792	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.41	5.35	4.07E-7	Longevity	
GBM	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.56	6.77	4.26E-10	Longevity	
GBM	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.57	-6.95	1.71E-10	Longevity	
GBM	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.57	-6.95	1.71E-10	Longevity	
GBM	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.41	6.64	8.42E-10	Kawasaki disease	
GBM	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1	-13.33	7.97E-26	Pediatric autoimmune diseases	
GBM	cis	1	rs4889609	chr16:31026427	MYST1	chr16:31128985-31142713:+	0.38	4.42	2.14E-5	Response to metformin (IC50)	
GBM	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.37	-5.11	1.18E-6	Common traits (Other)	
GBM	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.37	-5.11	1.18E-6	Common traits (Other)	
GBM	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.37	-5.11	1.18E-6	Common traits (Other)	
GBM	cis	1	rs4911178	chr20:33952620	CPNE1	chr20:34213968-34262539:-	0.54	5.39	3.32E-7	Height	
GBM	cis	1	rs4911178	chr20:33952620	UQCC	chr20:33890383-33999833:-	0.44	4.33	3.03E-5	Height	
GBM	cis	1	rs4911180	chr20:33972948	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs4911180	chr20:33972948	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs4911491	chr20:33947285	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs4911491	chr20:33947285	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs4911492	chr20:33951799	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs4911492	chr20:33951799	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs4911494	chr20:33971914	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs4911494	chr20:33971914	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs4911496	chr20:33972053	CPNE1	chr20:34213968-34262539:-	-0.54	-5.36	3.79E-7	Height	
GBM	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.5	-4.97	2.15E-6	Height	
GBM	cis	1	rs4919690	chr10:104616500	AS3MT	chr10:104613967-104661653:+	0.52	5.11	1.17E-6	Arsenic metabolism	
GBM	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.38	4.83	3.83E-6	Arsenic metabolism	
GBM	cis	1	rs4925166	chr17:18210810	LOC220594	chr17:18414577-18445234:-	-0.43	-4.82	4.14E-6	Multiple sclerosis	
GBM	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.67	-5.43	2.73E-7	Type 2 diabetes	
GBM	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.78	-6.99	1.45E-10	Type 2 diabetes	
GBM	cis	1	rs4970696	chr1:92968853	EVI5	chr1:92974255-93257961:-	-0.55	-4.95	2.3E-6	Cholesterol, total	
GBM	cis	1	rs4970698	chr1:92972933	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs4970705	chr1:92971828	EVI5	chr1:92974255-93257961:-	0.55	5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs4970708	chr1:92986514	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs4970709	chr1:92988592	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs4970710	chr1:92988717	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs4970712	chr1:92993547	EVI5	chr1:92974255-93257961:-	0.54	4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.71	-8.35	1.04E-13	Diastolic blood pressure	
GBM	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.48	-5.57	1.46E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.48	-5.57	1.46E-7	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs55508	chr17:64121059	CACNG4	chr17:64961013-65029518:+	-0.31	-4.27	3.76E-5	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	
GBM	cis	1	rs55674647	chr17:61794195	FTSJ3	chr17:61896795-61905031:-	0.46	4.98	2.08E-6	Body mass index	
GBM	cis	1	rs55775340	chr6:33751784	LEMD2	chr6:33738991-33756906:-	0.4	4.85	3.53E-6	Body mass index	
GBM	cis	1	rs55788133	chr15:40664239	C15orf23	chr15:40674922-40686488:+	0.74	5.28	5.45E-7	Heschl's gyrus morphology	
GBM	cis	1	rs55868506	chr17:61851686	FTSJ3	chr17:61896795-61905031:-	0.46	5.17	8.9E-7	Body mass index	
GBM	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.49	-4.84	3.7E-6	Inflammatory skin disease	
GBM	cis	1	rs55979739	chr16:31049155	MYST1	chr16:31128985-31142713:+	0.41	4.56	1.18E-5	Response to metformin (IC50)	
GBM	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.49	4.78	4.8E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
GBM	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.37	-4.79	4.57E-6	Esophageal cancer (squamous cell)	
GBM	cis	1	rs56057198	chr17:61733332	FTSJ3	chr17:61896795-61905031:-	0.43	4.75	5.43E-6	Body mass index	
GBM	cis	1	rs56077333	chr15:78899003	CHRNA5	chr15:78857906-78886458:+	-0.46	-4.49	1.6E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
GBM	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.76	7.96	8.67E-13	Diastolic blood pressure	
GBM	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.76	7.96	8.67E-13	Diastolic blood pressure	
GBM	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.81	7.74	2.74E-12	Diastolic blood pressure	
GBM	cis	1	rs56306402	chr20:33937704	CPNE1	chr20:34213968-34262539:-	0.54	5.32	4.56E-7	Height	
GBM	cis	1	rs56383601	chr17:61929968	FTSJ3	chr17:61896795-61905031:-	0.49	5.47	2.33E-7	Body mass index	
GBM	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.77	-8.52	4.1E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs57185954	chr17:46844961	SNX11	chr17:46184911-46200105:+	0.34	4.33	3.0E-5	Schizophrenia or bipolar disorder	
GBM	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	0.83	8.78	9.66E-15	Diastolic blood pressure	
GBM	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.42	-5.16	9.38E-7	Cognitive function	
GBM	cis	1	rs57576577	chr16:31036367	MYST1	chr16:31128985-31142713:+	0.38	4.42	2.14E-5	Response to metformin (IC50)	
GBM	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.42	-5.05	1.49E-6	Cognitive function	
GBM	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.44	-5.33	4.29E-7	Cognitive function	
GBM	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.44	-5.36	3.79E-7	Cognitive function	
GBM	cis	1	rs57912102	chr19:22136043	ZNF257	chr19:22235266-22273901:+	0.68	4.73	5.99E-6	Body mass index (change over time)	
GBM	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.56	-4.65	8.4E-6	Abdominal aortic aneurysm	
GBM	cis	1	rs59035163	chr10:65292043	NRBF2	chr10:64893007-64914785:+	0.68	6.14	9.92E-9	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.48	5.43	2.85E-7	Pancreatic cancer	
GBM	cis	1	rs59227481	chr12:110007993	KCTD10	chr12:109886460-109915155:-	-0.42	-5.06	1.45E-6	Age-related nuclear cataracts	
GBM	cis	1	rs59246603	chr10:65233942	JMJD1C	chr10:64926990-65225722:-	0.41	4.19	5.12E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs59246603	chr10:65233942	NRBF2	chr10:64893007-64914785:+	0.61	5.64	1.08E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs59376497	chr16:67681170	LRRC36	chr16:67360747-67419108:+	0.82	4.35	2.83E-5	Crohn's disease	
GBM	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.76	-8.43	6.86E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs6037086	chr20:25306338	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6037095	chr20:25335687	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6037099	chr20:25356876	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6037105	chr20:25374199	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6037121	chr20:25428311	FAM182A	chr20:26035250-26067552:+	-0.65	-6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6037526	chr20:3251248	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037532	chr20:3267911	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037533	chr20:3268817	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037535	chr20:3270621	ITPA	chr20:3190056-3204504:+	-0.52	-5.21	7.33E-7	IFN-related cytopenia	
GBM	cis	1	rs6037538	chr20:3282978	ITPA	chr20:3190056-3204504:+	-0.53	-5.11	1.15E-6	IFN-related cytopenia	
GBM	cis	1	rs6037547	chr20:3299228	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037551	chr20:3306690	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037553	chr20:3313884	ITPA	chr20:3190056-3204504:+	-0.52	-5.21	7.33E-7	IFN-related cytopenia	
GBM	cis	1	rs6037554	chr20:3315613	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037556	chr20:3317890	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037560	chr20:3323055	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037562	chr20:3326141	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037567	chr20:3332160	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037579	chr20:3347980	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037583	chr20:3360632	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6037590	chr20:3374085	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6050542	chr20:25318879	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050544	chr20:25320228	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050547	chr20:25326012	FAM182A	chr20:26035250-26067552:+	0.67	6.66	7.52E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050555	chr20:25328543	FAM182A	chr20:26035250-26067552:+	0.64	6.25	5.83E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050559	chr20:25329915	FAM182A	chr20:26035250-26067552:+	-0.66	-6.52	1.53E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050561	chr20:25334855	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050562	chr20:25336186	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050564	chr20:25344231	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050565	chr20:25347563	FAM182A	chr20:26035250-26067552:+	0.63	6.29	4.77E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050566	chr20:25351071	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050573	chr20:25366065	FAM182A	chr20:26035250-26067552:+	-0.67	-6.82	3.35E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050590	chr20:25384994	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050598	chr20:25397257	FAM182A	chr20:26035250-26067552:+	-0.64	-6.47	1.94E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050599	chr20:25400240	FAM182A	chr20:26035250-26067552:+	0.65	6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050602	chr20:25401203	FAM182A	chr20:26035250-26067552:+	0.65	6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050609	chr20:25411751	FAM182A	chr20:26035250-26067552:+	0.65	6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050617	chr20:25421648	FAM182A	chr20:26035250-26067552:+	-0.65	-6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050626	chr20:25428261	FAM182A	chr20:26035250-26067552:+	-0.65	-6.51	1.64E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050629	chr20:25430680	FAM182A	chr20:26035250-26067552:+	-0.65	-6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050630	chr20:25430745	FAM182A	chr20:26035250-26067552:+	-0.65	-6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050631	chr20:25431749	FAM182A	chr20:26035250-26067552:+	-0.66	-6.66	7.73E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6050632	chr20:25432601	FAM182A	chr20:26035250-26067552:+	-0.65	-6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.44	-5.83	4.31E-8	Longevity	
GBM	cis	1	rs6051672	chr20:3224819	ITPA	chr20:3190056-3204504:+	-0.49	-4.8	4.43E-6	IFN-related cytopenia	
GBM	cis	1	rs6051702	chr20:3251924	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051703	chr20:3252347	ITPA	chr20:3190056-3204504:+	-0.47	-4.72	6.14E-6	IFN-related cytopenia	
GBM	cis	1	rs6051705	chr20:3253143	ITPA	chr20:3190056-3204504:+	-0.47	-4.72	6.14E-6	IFN-related cytopenia	
GBM	cis	1	rs6051708	chr20:3262493	ITPA	chr20:3190056-3204504:+	-0.52	-5.21	7.33E-7	IFN-related cytopenia	
GBM	cis	1	rs6051709	chr20:3263685	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051712	chr20:3265029	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051713	chr20:3265779	ITPA	chr20:3190056-3204504:+	0.5	4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051715	chr20:3266548	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051716	chr20:3267736	ITPA	chr20:3190056-3204504:+	-0.55	-5.39	3.32E-7	IFN-related cytopenia	
GBM	cis	1	rs6051718	chr20:3270370	ITPA	chr20:3190056-3204504:+	-0.49	-4.87	3.28E-6	IFN-related cytopenia	
GBM	cis	1	rs6051722	chr20:3274435	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051723	chr20:3278512	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051724	chr20:3279338	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051732	chr20:3294182	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051736	chr20:3296898	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051737	chr20:3296992	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051745	chr20:3307243	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051747	chr20:3307945	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051751	chr20:3310049	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051753	chr20:3315513	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051762	chr20:3321590	ITPA	chr20:3190056-3204504:+	-0.55	-5.39	3.32E-7	IFN-related cytopenia	
GBM	cis	1	rs6051763	chr20:3321616	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.5	5.13	1.09E-6	IFN-related cytopenia	
GBM	cis	1	rs6051779	chr20:3333449	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051790	chr20:3342994	ITPA	chr20:3190056-3204504:+	-0.5	-4.93	2.52E-6	IFN-related cytopenia	
GBM	cis	1	rs6051792	chr20:3343519	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051806	chr20:3350319	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051807	chr20:3350485	ITPA	chr20:3190056-3204504:+	-0.55	-5.39	3.32E-7	IFN-related cytopenia	
GBM	cis	1	rs6051808	chr20:3350697	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051809	chr20:3352551	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051810	chr20:3355384	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051827	chr20:3372007	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6051831	chr20:3373712	ITPA	chr20:3190056-3204504:+	0.51	5.07	1.41E-6	IFN-related cytopenia	
GBM	cis	1	rs6051838	chr20:3389012	ITPA	chr20:3190056-3204504:+	-0.45	-4.44	1.95E-5	IFN-related cytopenia	
GBM	cis	1	rs6060401	chr20:34005214	CPNE1	chr20:34213968-34262539:-	0.54	5.27	5.75E-7	Height	
GBM	cis	1	rs6060402	chr20:34005240	CPNE1	chr20:34213968-34262539:-	0.54	5.26	6.1E-7	Height	
GBM	cis	1	rs6076336	chr20:25319212	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6076339	chr20:25348712	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6076345	chr20:25381895	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6083804	chr20:25317060	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6083805	chr20:25317356	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6083809	chr20:25329309	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6083813	chr20:25337671	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6083825	chr20:25366424	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6083828	chr20:25369918	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6083844	chr20:25386832	FAM182A	chr20:26035250-26067552:+	0.67	6.6	1.0E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6083856	chr20:25407585	FAM182A	chr20:26035250-26067552:+	0.66	6.59	1.11E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6083862	chr20:25411086	FAM182A	chr20:26035250-26067552:+	0.59	6.28	5.04E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6087698	chr20:33948919	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs6087698	chr20:33948919	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs6087702	chr20:33995945	CPNE1	chr20:34213968-34262539:-	0.54	5.24	6.45E-7	Height	
GBM	cis	1	rs6087703	chr20:33996433	CPNE1	chr20:34213968-34262539:-	0.53	5.16	9.24E-7	Height	
GBM	cis	1	rs6087704	chr20:34001058	CPNE1	chr20:34213968-34262539:-	0.53	5.1	1.2E-6	Height	
GBM	cis	1	rs6087705	chr20:34001250	CPNE1	chr20:34213968-34262539:-	0.53	5.18	8.45E-7	Height	
GBM	cis	1	rs6088799	chr20:33934301	CPNE1	chr20:34213968-34262539:-	0.55	5.39	3.28E-7	Height	
GBM	cis	1	rs6088799	chr20:33934301	UQCC	chr20:33890383-33999833:-	0.44	4.21	4.85E-5	Height	
GBM	cis	1	rs6088812	chr20:33974163	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs6088812	chr20:33974163	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs6088813	chr20:33975181	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs6088813	chr20:33975181	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs6088815	chr20:33976474	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs6088816	chr20:33982435	CPNE1	chr20:34213968-34262539:-	0.53	5.14	1.0E-6	Height	
GBM	cis	1	rs6088820	chr20:33987298	CPNE1	chr20:34213968-34262539:-	0.54	5.24	6.45E-7	Height	
GBM	cis	1	rs6088821	chr20:33987576	CPNE1	chr20:34213968-34262539:-	0.53	5.16	9.24E-7	Height	
GBM	cis	1	rs6088823	chr20:33994265	CPNE1	chr20:34213968-34262539:-	0.53	5.16	9.24E-7	Height	
GBM	cis	1	rs6088825	chr20:33995972	CPNE1	chr20:34213968-34262539:-	0.53	5.16	9.24E-7	Height	
GBM	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.42	-4.4	2.29E-5	Forced vital capacity	
GBM	cis	1	rs6107033	chr20:25363591	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6107045	chr20:25441936	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.35E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6107046	chr20:25442049	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.35E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6107047	chr20:25442097	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.35E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6115140	chr20:25285507	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6115146	chr20:25304507	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6115153	chr20:25325567	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6115159	chr20:25350944	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6115168	chr20:25372891	FAM182A	chr20:26035250-26067552:+	0.65	6.22	6.71E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6115182	chr20:25410259	FAM182A	chr20:26035250-26067552:+	0.65	6.48	1.84E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6115191	chr20:25440478	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.35E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.82	-7.68	3.76E-12	Triglycerides	
GBM	cis	1	rs6132835	chr20:25434667	FAM182A	chr20:26035250-26067552:+	-0.67	-6.76	4.59E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6133036	chr20:3349682	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs61360320	chr17:61800392	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs6138572	chr20:25435934	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.35E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6138575	chr20:25438952	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.35E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6139064	chr20:3277050	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6139068	chr20:3284393	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6139088	chr20:3329063	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6139103	chr20:3361140	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs6139117	chr20:3387785	ITPA	chr20:3190056-3204504:+	-0.47	-4.54	1.32E-5	IFN-related cytopenia	
GBM	cis	1	rs61394483	chr6:33751945	LEMD2	chr6:33738991-33756906:-	0.41	4.92	2.66E-6	Body mass index	
GBM	cis	1	rs6141546	chr20:33949282	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs6141546	chr20:33949282	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs6141548	chr20:33971085	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs6141548	chr20:33971085	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs6141549	chr20:33974051	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs6141549	chr20:33974051	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs6142358	chr20:33960308	CPNE1	chr20:34213968-34262539:-	-0.53	-5.17	9.06E-7	Height	
GBM	cis	1	rs6142359	chr20:33960450	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs6142359	chr20:33960450	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs6142360	chr20:33960486	CPNE1	chr20:34213968-34262539:-	0.53	5.12	1.1E-6	Height	
GBM	cis	1	rs6142360	chr20:33960486	UQCC	chr20:33890383-33999833:-	0.44	4.21	4.76E-5	Height	
GBM	cis	1	rs6142369	chr20:33973315	CPNE1	chr20:34213968-34262539:-	0.54	5.32	4.56E-7	Height	
GBM	cis	1	rs6142370	chr20:33973378	CPNE1	chr20:34213968-34262539:-	0.55	5.4	3.17E-7	Height	
GBM	cis	1	rs6142370	chr20:33973378	UQCC	chr20:33890383-33999833:-	0.44	4.23	4.53E-5	Height	
GBM	cis	1	rs6142373	chr20:33983314	CPNE1	chr20:34213968-34262539:-	0.54	5.24	6.45E-7	Height	
GBM	cis	1	rs6142374	chr20:33985568	CPNE1	chr20:34213968-34262539:-	0.53	5.16	9.24E-7	Height	
GBM	cis	1	rs6142376	chr20:33992761	CPNE1	chr20:34213968-34262539:-	0.53	5.16	9.24E-7	Height	
GBM	cis	1	rs6142379	chr20:33999267	CPNE1	chr20:34213968-34262539:-	0.53	5.1	1.2E-6	Height	
GBM	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-0.87	-6.22	6.84E-9	Blood metabolite levels	
GBM	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.5	4.51	1.45E-5	Metabolite levels (small molecules and protein measures)	
GBM	cis	1	rs61579729	chr10:65319313	NRBF2	chr10:64893007-64914785:+	0.72	6.04	1.6E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs61662306	chr6:33746697	LEMD2	chr6:33738991-33756906:-	0.41	4.94	2.46E-6	Body mass index	
GBM	cis	1	rs61744385	chr3:41756986	ULK4	chr3:41288091-42003660:-	0.82	8.23	1.99E-13	Diastolic blood pressure	
GBM	cis	1	rs61744388	chr3:41756965	ULK4	chr3:41288091-42003660:-	0.82	8.23	1.99E-13	Diastolic blood pressure	
GBM	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.61	4.68	7.18E-6	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs61826828	chr1:174015261	SERPINC1	chr1:173872943-173886516:-	0.58	4.64	8.67E-6	Schizophrenia	
GBM	cis	1	rs61853336	chr10:64899875	NRBF2	chr10:64893007-64914785:+	0.68	5.56	1.51E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs61853589	chr10:65187111	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs61853635	chr10:65276510	NRBF2	chr10:64893007-64914785:+	0.66	5.97	2.26E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs61855465	chr10:64956607	NRBF2	chr10:64893007-64914785:+	0.58	4.94	2.42E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs62112907	chr19:22209569	ZNF257	chr19:22235266-22273901:+	0.66	4.47	1.69E-5	Body mass index (change over time)	
GBM	cis	1	rs62112917	chr19:22226580	ZNF257	chr19:22235266-22273901:+	0.67	4.43	1.99E-5	Body mass index (change over time)	
GBM	cis	1	rs62211529	chr20:33959315	CPNE1	chr20:34213968-34262539:-	0.54	5.32	4.56E-7	Height	
GBM	cis	1	rs62402013	chr6:26915000	C6orf41	chr6:26924772-26991752:+	-0.51	-5.59	1.34E-7	Schizophrenia	
GBM	cis	1	rs62402013	chr6:26915000	LOC100270746	chr6:26987146-26988085:-	-0.61	-6.33	3.9E-9	Schizophrenia	
GBM	cis	1	rs63749191	chr10:65119887	NRBF2	chr10:64893007-64914785:+	0.59	5.31	4.82E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs6422512	chr1:93024844	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.39	4.19	5.13E-5	Height	
GBM	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.45	-5.56	1.52E-7	Homocysteine levels	
GBM	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.02	1.74E-6	Homocysteine levels	
GBM	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.41	5.4	3.25E-7	Longevity	
GBM	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.39	-5.27	5.69E-7	Longevity	
GBM	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.39	-5.25	6.17E-7	Longevity	
GBM	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.42	-5.74	6.78E-8	Longevity	
GBM	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.42	-5.62	1.17E-7	Longevity	
GBM	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.94	10.38	1.27E-18	Type 2 diabetes	
GBM	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.68	8.17	2.84E-13	Response to antipsychotic treatment	
GBM	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.74	-8.28	1.53E-13	Erythrocyte sedimentation rate	
GBM	cis	1	rs6477998	chr9:115997249	CDC26	chr9:116029290-116037869:-	0.47	4.7	6.76E-6	Hematology traits	
GBM	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.62	-5.6	1.26E-7	Rheumatoid arthritis	
GBM	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.64	-5.62	1.18E-7	Rheumatoid arthritis	
GBM	cis	1	rs6479891	chr10:65006456	NRBF2	chr10:64893007-64914785:+	0.64	5.41	3.11E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs6479894	chr10:65098741	ADO	chr10:64564516-64568238:+	-0.49	-4.3	3.39E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs6479894	chr10:65098741	NRBF2	chr10:64893007-64914785:+	-0.66	-5.79	5.37E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs6479899	chr10:65139047	NRBF2	chr10:64893007-64914785:+	-0.59	-5.31	4.87E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.02	1.74E-6	Forced vital capacity	
GBM	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.45	4.98	2.02E-6	Forced vital capacity	
GBM	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.78	-6.43	2.34E-9	Type 2 diabetes	
GBM	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.77	-8.52	4.1E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs6504167	chr17:61693194	FTSJ3	chr17:61896795-61905031:-	0.4	4.25	4.16E-5	Body mass index	
GBM	cis	1	rs6504168	chr17:61697469	FTSJ3	chr17:61896795-61905031:-	0.41	4.45	1.86E-5	Body mass index	
GBM	cis	1	rs6504169	chr17:61709145	FTSJ3	chr17:61896795-61905031:-	0.45	4.99	1.94E-6	Body mass index	
GBM	cis	1	rs6504170	chr17:61709168	FTSJ3	chr17:61896795-61905031:-	0.43	4.8	4.45E-6	Body mass index	
GBM	cis	1	rs6504171	chr17:61710010	FTSJ3	chr17:61896795-61905031:-	0.43	4.77	5.04E-6	Body mass index	
GBM	cis	1	rs6504173	chr17:61735056	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs6504182	chr17:61823672	FTSJ3	chr17:61896795-61905031:-	0.45	5.06	1.47E-6	Body mass index	
GBM	cis	1	rs6510348	chr19:33601946	GPATCH1	chr19:33571786-33621318:+	0.4	4.5	1.54E-5	Bone properties (heel)	
GBM	cis	1	rs6510348	chr19:33601946	RHPN2	chr19:33469499-33555824:-	-0.38	-4.24	4.27E-5	Bone properties (heel)	
GBM	cis	1	rs6515651	chr20:25414539	FAM182A	chr20:26035250-26067552:+	0.66	6.66	7.73E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs6515773	chr20:3174105	ITPA	chr20:3190056-3204504:+	0.36	4.19	5.29E-5	Night sleep phenotypes	
GBM	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.58	-7	1.33E-10	Longevity	
GBM	cis	1	rs6536365	chr4:159632293	ETFDH	chr4:159593277-159629839:+	-0.47	-4.41	2.2E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
GBM	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.51	5.5	2.0E-7	Tuberculosis	
GBM	cis	1	rs6579234	chr20:33983485	CPNE1	chr20:34213968-34262539:-	0.54	5.24	6.45E-7	Height	
GBM	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.81	-7.62	5.42E-12	Cholesterol, total	
GBM	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.5	4.22	4.59E-5	Multiple sclerosis	
GBM	cis	1	rs6599170	chr3:41772718	ULK4	chr3:41288091-42003660:-	0.84	8.78	1.02E-14	Diastolic blood pressure	
GBM	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.78	-8.35	1.03E-13	Diastolic blood pressure	
GBM	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.79	-8.66	1.96E-14	Diastolic blood pressure	
GBM	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	0.76	8.72	1.37E-14	Diastolic blood pressure	
GBM	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	0.77	9.05	2.17E-15	Diastolic blood pressure	
GBM	cis	1	rs6603975	chr1:92951239	EVI5	chr1:92974255-93257961:-	-0.55	-4.95	2.3E-6	Cholesterol, total	
GBM	cis	1	rs6603979	chr1:92979354	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs6603981	chr1:92993807	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs6603982	chr1:92994033	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs6603984	chr1:93011572	EVI5	chr1:92974255-93257961:-	-0.54	-4.96	2.23E-6	Cholesterol, total	
GBM	cis	1	rs6603985	chr1:93017159	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs6603987	chr1:93019313	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs6603990	chr1:93030735	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs6656432	chr1:93029453	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs6661134	chr1:93010908	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.44	-5.52	1.81E-7	Homocysteine levels	
GBM	cis	1	rs6679073	chr1:205756484	PM20D1	chr1:205797154-205819245:-	-0.58	-4.58	1.09E-5	Prostate-specific antigen levels	
GBM	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.59	4.56	1.19E-5	Diastolic blood pressure;Blood pressure	
GBM	cis	1	rs6690764	chr1:92976590	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs6692187	chr1:93035020	EVI5	chr1:92974255-93257961:-	-0.55	-5.27	5.66E-7	Cholesterol, total	
GBM	cis	1	rs6694079	chr1:220076273	BPNT1	chr1:220230826-220263191:-	0.37	4.28	3.68E-5	Urinary electrolytes (magnesium/calcium ratio)	
GBM	cis	1	rs6694088	chr1:220076288	BPNT1	chr1:220230826-220263191:-	0.37	4.27	3.79E-5	Urinary electrolytes (magnesium/calcium ratio)	
GBM	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.39	-4.19	5.12E-5	Height	
GBM	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.84	-6.33	3.95E-9	Rheumatoid arthritis	
GBM	cis	1	rs6711941	chr2:202178130	CFLAR	chr2:201980816-202029001:+	-0.62	-4.64	8.64E-6	Rheumatoid arthritis	
GBM	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.79	-6.19	7.98E-9	Rheumatoid arthritis	
GBM	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.72	-6.07	1.36E-8	Rheumatoid arthritis	
GBM	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.84	-6.33	3.95E-9	Rheumatoid arthritis	
GBM	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.75	-5.04	1.59E-6	Plasma clusterin levels	
GBM	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.73	-4.87	3.34E-6	Plasma clusterin levels	
GBM	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.54	5.91	3.0E-8	Tuberculosis	
GBM	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.61	-5.69	8.44E-8	Triptolide cytotoxicity	
GBM	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.65	-6.05	1.53E-8	Triptolide cytotoxicity	
GBM	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	0.76	9.01	2.8E-15	Diastolic blood pressure	
GBM	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.73	8.07	4.82E-13	Diastolic blood pressure	
GBM	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.73	8.07	4.82E-13	Diastolic blood pressure	
GBM	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.73	8.07	4.82E-13	Diastolic blood pressure	
GBM	cis	1	rs67696450	chr10:1090684	IDI2	chr10:1064847-1071799:-	-0.48	-4.64	8.44E-6	Response to angiotensin II receptor blocker therapy	
GBM	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.42	-5.63	1.1E-7	Longevity	
GBM	cis	1	rs6770670	chr3:49686682	LAMB2L	chr3:49190293-49191834:-	0.51	4.83	3.85E-6	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.41	-5.51	1.91E-7	Longevity	
GBM	cis	1	rs6781326	chr3:41777028	ULK4	chr3:41288091-42003660:-	0.83	8.75	1.18E-14	Diastolic blood pressure	
GBM	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.76	8.91	4.88E-15	Diastolic blood pressure	
GBM	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.39	-5.2	7.84E-7	Longevity	
GBM	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.79	7.82	1.81E-12	Diastolic blood pressure	
GBM	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.45	-5.92	2.79E-8	Longevity	
GBM	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	0.77	8.87	6.16E-15	Diastolic blood pressure	
GBM	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.4	-5.34	4.13E-7	Longevity	
GBM	cis	1	rs6797165	chr3:41887777	ULK4	chr3:41288091-42003660:-	0.77	9.08	1.93E-15	Diastolic blood pressure	
GBM	cis	1	rs6801343	chr3:41767234	ULK4	chr3:41288091-42003660:-	0.84	8.7	1.54E-14	Diastolic blood pressure	
GBM	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.71	8.26	1.67E-13	Diastolic blood pressure	
GBM	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.71	8.26	1.67E-13	Diastolic blood pressure	
GBM	cis	1	rs6804655	chr3:49738945	RBM6	chr3:49977592-50137484:+	-0.36	-5.09	1.29E-6	Resting heart rate	
GBM	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.4	-5.34	4.13E-7	Longevity	
GBM	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.73	8.07	4.82E-13	Diastolic blood pressure	
GBM	cis	1	rs6807015	chr3:41754514	ULK4	chr3:41288091-42003660:-	0.82	8.23	1.99E-13	Diastolic blood pressure	
GBM	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.42	-5.63	1.1E-7	Longevity	
GBM	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.68	-8.3	1.39E-13	Response to antipsychotic treatment	
GBM	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.58	-7	1.33E-10	Longevity	
GBM	cis	1	rs6832503	chr4:48028442	CNGA1	chr4:47937996-48018610:-	-0.62	-6.21	7.15E-9	Renal underexcretion gout;Gout	
GBM	cis	1	rs6874202	chr5:156391628	TIMD4	chr5:156346293-156390266:-	-0.5	-5.38	3.46E-7	Triglycerides;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs6878680	chr5:156387137	TIMD4	chr5:156346293-156390266:-	-0.47	-4.95	2.34E-6	Triglycerides;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs6882076	chr5:156390297	TIMD4	chr5:156346293-156390266:-	-0.5	-5.38	3.46E-7	Triglycerides;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.67	-8.51	4.43E-14	Response to antipsychotic treatment	
GBM	cis	1	rs6921487	chr6:33749293	LEMD2	chr6:33738991-33756906:-	0.38	4.61	9.59E-6	Body mass index	
GBM	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.68	8.25	1.85E-13	Response to antipsychotic treatment	
GBM	cis	1	rs6930201	chr6:33738749	LEMD2	chr6:33738991-33756906:-	0.42	4.97	2.11E-6	Body mass index	
GBM	cis	1	rs6933174	chr6:33751003	LEMD2	chr6:33738991-33756906:-	0.41	4.92	2.66E-6	Body mass index	
GBM	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.59	7.92	1.05E-12	Response to antipsychotic treatment	
GBM	cis	1	rs6933568	chr6:33751261	LEMD2	chr6:33738991-33756906:-	0.41	4.92	2.66E-6	Body mass index	
GBM	cis	1	rs6933607	chr6:33743997	LEMD2	chr6:33738991-33756906:-	0.41	4.94	2.46E-6	Body mass index	
GBM	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.66	-8.4	8.09E-14	Response to antipsychotic treatment	
GBM	cis	1	rs6940353	chr6:33752550	LEMD2	chr6:33738991-33756906:-	0.41	4.92	2.66E-6	Body mass index	
GBM	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.68	-8.74	1.25E-14	Response to antipsychotic treatment	
GBM	cis	1	rs6970597	chr7:21583519	DNAH11	chr7:21582833-21941455:+	-0.58	-6.33	4.03E-9	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
GBM	cis	1	rs6970985	chr7:21583597	DNAH11	chr7:21582833-21941455:+	-0.58	-6.33	4.03E-9	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
GBM	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.68	7.81	1.9E-12	Bone mineral density	
GBM	cis	1	rs7014273	chr8:67358694	ADHFE1	chr8:67344718-67381042:+	0.32	4.22	4.72E-5	Blood metabolite levels	
GBM	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.69	8.06	4.96E-13	Bone mineral density	
GBM	cis	1	rs7018	chr20:25278261	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs7019	chr20:25278278	FAM182A	chr20:26035250-26067552:+	-0.67	-6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs7020	chr20:25278600	FAM182A	chr20:26035250-26067552:+	-0.68	-6.78	4.08E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.52	-5.3	5.1E-7	Hematology traits	
GBM	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.63	-5.55	1.63E-7	Rheumatoid arthritis	
GBM	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.52	-5.3	5.1E-7	Hematology traits	
GBM	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.75	8.64	2.16E-14	Cognitive function	
GBM	cis	1	rs7070052	chr10:64903814	NRBF2	chr10:64893007-64914785:+	-0.67	-5.35	4.06E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs7081275	chr10:65106551	NRBF2	chr10:64893007-64914785:+	-0.63	-5.66	9.61E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs7087279	chr10:65291936	NRBF2	chr10:64893007-64914785:+	-0.67	-6.05	1.55E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.76	-8.43	6.86E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs7099425	chr10:64960717	NRBF2	chr10:64893007-64914785:+	-0.58	-4.94	2.42E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.74	-6.05	1.51E-8	Type 2 diabetes	
GBM	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.42	-4.4	2.29E-5	Forced vital capacity	
GBM	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.86	6.63	9.0E-10	Metabolite levels (HVA/5-HIAA ratio)	
GBM	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.38	5.07	1.36E-6	Common traits (Other)	
GBM	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.39	5.43	2.79E-7	Common traits (Other)	
GBM	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.4	-5.54	1.69E-7	Common traits (Other)	
GBM	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	0.56	4.33	2.96E-5	Heschl's gyrus morphology	
GBM	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.81	6.06	1.47E-8	Heschl's gyrus morphology	
GBM	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	0.55	4.29	3.5E-5	Heschl's gyrus morphology	
GBM	cis	1	rs7182567	chr15:79045054	ADAMTS7	chr15:79051546-79103773:-	0.34	4.41	2.16E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs7182694	chr15:79045030	ADAMTS7	chr15:79051546-79103773:-	0.33	4.31	3.22E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs7182993	chr15:79045014	ADAMTS7	chr15:79051546-79103773:-	0.33	4.31	3.22E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.39	5.32	4.56E-7	Height	
GBM	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.68	8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs7209435	chr17:61712964	FTSJ3	chr17:61896795-61905031:-	0.43	4.77	5.04E-6	Body mass index	
GBM	cis	1	rs7209758	chr17:61913621	FTSJ3	chr17:61896795-61905031:-	0.48	5.48	2.24E-7	Body mass index	
GBM	cis	1	rs7211213	chr17:61769456	FTSJ3	chr17:61896795-61905031:-	0.41	4.56	1.18E-5	Body mass index	
GBM	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.68	8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.76	-8.43	6.86E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs7214312	chr17:61870863	FTSJ3	chr17:61896795-61905031:-	0.46	5.17	8.9E-7	Body mass index	
GBM	cis	1	rs7216798	chr17:61740963	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs7217982	chr17:61832150	FTSJ3	chr17:61896795-61905031:-	0.46	5.05	1.51E-6	Body mass index	
GBM	cis	1	rs7220821	chr17:61704147	FTSJ3	chr17:61896795-61905031:-	0.43	4.77	5.04E-6	Body mass index	
GBM	cis	1	rs7220892	chr17:61908316	FTSJ3	chr17:61896795-61905031:-	0.48	5.48	2.24E-7	Body mass index	
GBM	cis	1	rs722133	chr3:150892493	CLRN1OS	chr3:150570271-150797617:+	-0.65	-4.36	2.64E-5	Heschl's gyrus morphology	
GBM	cis	1	rs7222060	chr17:61868279	FTSJ3	chr17:61896795-61905031:-	0.46	5.17	8.9E-7	Body mass index	
GBM	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.68	8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs7223412	chr17:61808172	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.68	-8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs7223672	chr17:61720565	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs7223966	chr17:61893398	FTSJ3	chr17:61896795-61905031:-	0.49	5.5	2.07E-7	Body mass index	
GBM	cis	1	rs724553	chr10:65140384	NRBF2	chr10:64893007-64914785:+	0.59	5.31	4.87E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.39	5.19	8.31E-7	Longevity	
GBM	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.38	4.97	2.15E-6	Longevity	
GBM	cis	1	rs7254758	chr19:33608047	GPATCH1	chr19:33571786-33621318:+	0.4	4.5	1.54E-5	Bone properties (heel)	
GBM	cis	1	rs7254758	chr19:33608047	RHPN2	chr19:33469499-33555824:-	-0.38	-4.24	4.27E-5	Bone properties (heel)	
GBM	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.6	5.65	1.02E-7	Schizophrenia	
GBM	cis	1	rs7255968	chr19:33601902	GPATCH1	chr19:33571786-33621318:+	0.43	4.49	1.59E-5	Bone properties (heel)	
GBM	cis	1	rs7255968	chr19:33601902	RHPN2	chr19:33469499-33555824:-	-0.41	-4.26	3.92E-5	Bone properties (heel)	
GBM	cis	1	rs725908	chr20:33968067	CPNE1	chr20:34213968-34262539:-	0.53	5.12	1.1E-6	Height	
GBM	cis	1	rs725908	chr20:33968067	UQCC	chr20:33890383-33999833:-	0.44	4.21	4.76E-5	Height	
GBM	cis	1	rs7267979	chr20:25298087	FAM182A	chr20:26035250-26067552:+	-0.68	-6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs7268053	chr20:25328286	FAM182A	chr20:26035250-26067552:+	0.66	6.56	1.26E-9	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.5	-4.35	2.74E-5	Abdominal aortic aneurysm	
GBM	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.36	-4.82	4.08E-6	Esophageal cancer (squamous cell)	
GBM	cis	1	rs72829170	chr10:64940289	NRBF2	chr10:64893007-64914785:+	0.58	4.99	1.95E-6	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs72837025	chr10:65194491	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs72837056	chr10:65260478	JMJD1C	chr10:64926990-65225722:-	0.42	4.17	5.57E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs72837056	chr10:65260478	NRBF2	chr10:64893007-64914785:+	0.65	5.82	4.55E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs72837070	chr10:65274679	NRBF2	chr10:64893007-64914785:+	0.66	5.97	2.26E-8	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs72848797	chr17:61934664	FTSJ3	chr17:61896795-61905031:-	0.49	5.47	2.33E-7	Body mass index	
GBM	cis	1	rs72934944	chr2:202190610	CFLAR	chr2:201980816-202029001:+	-0.61	-4.61	9.9E-6	Rheumatoid arthritis	
GBM	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.78	-6.11	1.16E-8	Rheumatoid arthritis	
GBM	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.84	-6.33	3.95E-9	Rheumatoid arthritis	
GBM	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.84	-6.33	3.95E-9	Rheumatoid arthritis	
GBM	cis	1	rs72934999	chr2:202223524	CFLAR	chr2:201980816-202029001:+	-0.62	-4.37	2.62E-5	Rheumatoid arthritis	
GBM	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.85	-6.31	4.32E-9	Rheumatoid arthritis	
GBM	cis	1	rs72937106	chr2:202225520	CFLAR	chr2:201980816-202029001:+	-0.62	-4.37	2.62E-5	Rheumatoid arthritis	
GBM	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.85	-6.31	4.32E-9	Rheumatoid arthritis	
GBM	cis	1	rs72937118	chr2:202229527	CFLAR	chr2:201980816-202029001:+	-0.62	-4.37	2.62E-5	Rheumatoid arthritis	
GBM	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.85	-6.31	4.32E-9	Rheumatoid arthritis	
GBM	cis	1	rs72937120	chr2:202232611	CFLAR	chr2:201980816-202029001:+	-0.66	-4.59	1.04E-5	Rheumatoid arthritis	
GBM	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.87	-6.38	3.04E-9	Rheumatoid arthritis	
GBM	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.75	7.89	1.28E-12	Diastolic blood pressure	
GBM	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.82	8.86	6.49E-15	Diastolic blood pressure	
GBM	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.82	8.86	6.49E-15	Diastolic blood pressure	
GBM	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.7	8.03	5.8E-13	Diastolic blood pressure	
GBM	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.4	-5.34	4.13E-7	Longevity	
GBM	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.75	8.78	9.65E-15	Diastolic blood pressure	
GBM	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.76	8.02	6.27E-13	Diastolic blood pressure	
GBM	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.76	7.96	8.67E-13	Diastolic blood pressure	
GBM	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.76	7.96	8.67E-13	Diastolic blood pressure	
GBM	cis	1	rs7309927	chr12:1000185	RAD52	chr12:1021255-1099219:-	-0.5	-4.57	1.16E-5	Colorectal cancer	
GBM	cis	1	rs732172	chr16:31050033	MYST1	chr16:31128985-31142713:+	0.41	4.56	1.18E-5	Response to metformin (IC50)	
GBM	cis	1	rs732173	chr16:31050023	MYST1	chr16:31128985-31142713:+	0.41	4.56	1.18E-5	Response to metformin (IC50)	
GBM	cis	1	rs73337598	chr17:61732576	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs7336933	chr13:42559076	ELF1	chr13:41506056-41593508:-	0.4	4.16	5.82E-5	Calcium levels	
GBM	cis	1	rs73412140	chr6:33757014	LEMD2	chr6:33738991-33756906:-	0.41	4.92	2.66E-6	Body mass index	
GBM	cis	1	rs7343481	chr20:25300113	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs735531	chr20:33947730	CPNE1	chr20:34213968-34262539:-	0.54	5.32	4.56E-7	Height	
GBM	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-0.79	-9.28	6.19E-16	Diastolic blood pressure	
GBM	cis	1	rs74019800	chr16:58159888	CNOT1	chr16:58553856-58663750:-	0.61	4.4	2.28E-5	Telomere length	
GBM	cis	1	rs74019802	chr16:58162210	CNOT1	chr16:58553856-58663750:-	0.62	4.28	3.72E-5	Telomere length	
GBM	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.7	8.39	8.23E-14	Eye color traits	
GBM	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.72	-4.96	2.24E-6	Plasma clusterin levels	
GBM	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.57	-6.95	1.71E-10	Longevity	
GBM	cis	1	rs74363821	chr6:26189524	HIST1H3E	chr6:26224427-26226589:+	0.87	5.86	3.78E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs747692	chr6:33737436	LEMD2	chr6:33738991-33756906:-	0.42	4.9	2.92E-6	Body mass index	
GBM	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.68	8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs751096	chr6:33742838	LEMD2	chr6:33738991-33756906:-	-0.38	-4.18	5.5E-5	Body mass index	
GBM	cis	1	rs7515577	chr1:93009438	EVI5	chr1:92974255-93257961:-	-0.55	-5.09	1.28E-6	Cholesterol, total	
GBM	cis	1	rs75159543	chr15:40665228	C15orf23	chr15:40674922-40686488:+	0.74	5.28	5.45E-7	Heschl's gyrus morphology	
GBM	cis	1	rs75167249	chr19:22128655	ZNF257	chr19:22235266-22273901:+	0.62	4.2	5.07E-5	Body mass index (change over time)	
GBM	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.74	-5.01	1.83E-6	Plasma clusterin levels	
GBM	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.41	4.95	2.29E-6	Homocysteine levels	
GBM	cis	1	rs7524258	chr1:7292229	ZBTB48	chr1:6640056-6649339:+	-0.43	-4.36	2.69E-5	Tourette's syndrome or obsessive-compulsive disorder	
GBM	cis	1	rs752621	chr17:61901880	FTSJ3	chr17:61896795-61905031:-	0.49	5.45	2.52E-7	Body mass index	
GBM	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	0.56	4.33	2.96E-5	Heschl's gyrus morphology	
GBM	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.74	-4.98	2.03E-6	Plasma clusterin levels	
GBM	cis	1	rs7533348	chr1:220077269	BPNT1	chr1:220230826-220263191:-	0.37	4.21	4.79E-5	Urinary electrolytes (magnesium/calcium ratio)	
GBM	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.43	-5.48	2.27E-7	Homocysteine levels	
GBM	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.2	7.71E-7	Homocysteine levels	
GBM	cis	1	rs755495	chr6:33734128	LEMD2	chr6:33738991-33756906:-	-0.35	-4.16	5.85E-5	Body mass index	
GBM	cis	1	rs7577696	chr2:32278782	NLRC4	chr2:32449518-32490801:-	-0.27	-4.53	1.36E-5	Inflammatory biomarkers	
GBM	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.4	5.44	2.69E-7	Common traits (Other)	
GBM	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.66	-4.32	3.09E-5	Plasma clusterin levels	
GBM	cis	1	rs7591472	chr2:201889751	CFLAR	chr2:201980816-202029001:+	-0.51	-4.62	9.42E-6	Triptolide cytotoxicity	
GBM	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.76	-7.53	8.54E-12	Triptolide cytotoxicity	
GBM	cis	1	rs75921373	chr6:26191843	HIST1H3E	chr6:26224427-26226589:+	0.82	5.45	2.5E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.44	4.6	1.03E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
GBM	cis	1	rs7608623	chr2:23948953	LOC375190	chr2:24299728-24397519:+	0.36	4.39	2.35E-5	Obesity-related traits	
GBM	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.42	4.34	2.91E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
GBM	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.44	-4.61	9.62E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
GBM	cis	1	rs761025	chr20:25426968	FAM182A	chr20:26035250-26067552:+	-0.66	-6.66	7.73E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.7	-6.64	8.38E-10	Blood pressure (smoking interaction)	
GBM	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.81	7.34	2.29E-11	Blood pressure (smoking interaction)	
GBM	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.76	9.01	2.8E-15	Diastolic blood pressure	
GBM	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.72	-8.39	8.5E-14	Diastolic blood pressure	
GBM	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.73	8.49	4.99E-14	Diastolic blood pressure	
GBM	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.38	5.04	1.58E-6	Height	
GBM	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.4	-5.27	5.81E-7	Longevity	
GBM	cis	1	rs7631057	chr3:41817951	ULK4	chr3:41288091-42003660:-	0.73	8.2	2.38E-13	Diastolic blood pressure	
GBM	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.8	8.96	3.74E-15	Diastolic blood pressure	
GBM	cis	1	rs76329209	chr6:26196430	HIST1H3E	chr6:26224427-26226589:+	0.85	5.67	9.22E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.39	-5.25	6.24E-7	Longevity	
GBM	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.37	-4.9	2.85E-6	Longevity	
GBM	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.44	-5.83	4.31E-8	Longevity	
GBM	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.37	-4.82	3.98E-6	Longevity	
GBM	cis	1	rs76434589	chr7:106717217	COG5	chr7:106842189-107204959:-	-0.59	-4.26	4.02E-5	Bladder cancer (smoking interaction)	
GBM	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.8	8.96	3.74E-15	Diastolic blood pressure	
GBM	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	0.83	8.78	9.66E-15	Diastolic blood pressure	
GBM	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	0.76	8.72	1.37E-14	Diastolic blood pressure	
GBM	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.77	9.09	1.78E-15	Diastolic blood pressure	
GBM	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.82	8.86	6.49E-15	Diastolic blood pressure	
GBM	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.39	-5.28	5.39E-7	Longevity	
GBM	cis	1	rs76525880	chr17:46614250	ABI3	chr17:47287589-47300587:+	0.55	4.98	2.03E-6	Colorectal or endometrial cancer	
GBM	cis	1	rs76525880	chr17:46614250	GNGT2	chr17:47283597-47286743:-	0.49	4.3	3.34E-5	Colorectal or endometrial cancer	
GBM	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.41	5.4	3.18E-7	Longevity	
GBM	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.71	-4.71	6.42E-6	Tumor biomarkers	
GBM	cis	1	rs7655841	chr4:129890790	C4orf33	chr4:130014829-130033842:+	0.45	5.04	1.55E-6	Chronic obstructive pulmonary disease (moderate to severe)	
GBM	cis	1	rs76722536	chr6:26192946	HIST1H3E	chr6:26224427-26226589:+	0.85	5.26	6.1E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	0.73	5.32	4.64E-7	Heschl's gyrus morphology	
GBM	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.08	16.66	1.2E-33	Birdshot chorioretinopathy	
GBM	cis	1	rs7742038	chr6:124240560	NKAIN2	chr6:124125069-125146784:+	-0.3	-4.33	3.06E-5	Gut microbiome composition (summer)	
GBM	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.66	-8.36	1.01E-13	Response to antipsychotic treatment	
GBM	cis	1	rs77494594	chr10:65197309	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	0.54	4.19	5.16E-5	Heschl's gyrus morphology	
GBM	cis	1	rs7755323	chr6:33761159	LEMD2	chr6:33738991-33756906:-	0.4	4.95	2.31E-6	Body mass index	
GBM	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.7	-8.67	1.77E-14	Response to antipsychotic treatment	
GBM	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.65	-8.25	1.84E-13	Response to antipsychotic treatment	
GBM	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.66	-8.5	4.71E-14	Response to antipsychotic treatment	
GBM	cis	1	rs77763497	chr20:3250007	ITPA	chr20:3190056-3204504:+	-0.47	-4.72	6.14E-6	IFN-related cytopenia	
GBM	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.55	5.96	2.35E-8	Tuberculosis	
GBM	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.55	5.96	2.35E-8	Tuberculosis	
GBM	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.58	6.5	1.69E-9	Tuberculosis	
GBM	cis	1	rs77957229	chr6:26185226	HIST1H3E	chr6:26224427-26226589:+	0.81	5.06	1.44E-6	Renal underexcretion gout;Gout	
GBM	cis	1	rs77961951	chr6:26186075	HIST1H3E	chr6:26224427-26226589:+	0.84	5.27	5.77E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs78012445	chr6:26195080	HIST1H3E	chr6:26224427-26226589:+	0.82	5.45	2.5E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	0.54	4.19	5.16E-5	Heschl's gyrus morphology	
GBM	cis	1	rs78172786	chr17:61847114	FTSJ3	chr17:61896795-61905031:-	0.46	5	1.86E-6	Body mass index	
GBM	cis	1	rs7822232	chr8:145145687	KIAA1875	chr8:145162629-145173218:+	-0.44	-5.18	8.42E-7	Blood metabolite levels	
GBM	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	0.56	4.33	2.96E-5	Heschl's gyrus morphology	
GBM	cis	1	rs78953187	chr1:93000574	EVI5	chr1:92974255-93257961:-	-0.53	-4.78	4.72E-6	Cholesterol, total	
GBM	cis	1	rs7895348	chr10:65109541	NRBF2	chr10:64893007-64914785:+	-0.57	-5.2	7.77E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	0.56	4.33	2.96E-5	Heschl's gyrus morphology	
GBM	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.66	8.15	3.16E-13	Response to antipsychotic treatment	
GBM	cis	1	rs79264785	chr6:26194121	HIST1H3E	chr6:26224427-26226589:+	0.85	5.67	9.22E-8	Renal underexcretion gout;Gout	
GBM	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.49	5.57	1.47E-7	Pancreatic cancer	
GBM	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	0.83	8.78	9.66E-15	Diastolic blood pressure	
GBM	cis	1	rs7957145	chr12:57302120	ESYT1	chr12:56522054-56538452:+	-0.48	-4.21	4.74E-5	Airway wall thickness	
GBM	cis	1	rs79846980	chr19:22141343	ZNF257	chr19:22235266-22273901:+	0.68	4.73	5.99E-6	Body mass index (change over time)	
GBM	cis	1	rs79868973	chr6:26189312	HIST1H3E	chr6:26224427-26226589:+	0.84	5.64	1.09E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs80095925	chr6:26184942	HIST1H3E	chr6:26224427-26226589:+	0.84	5.27	5.77E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.68	4.21	4.88E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
GBM	cis	1	rs80259160	chr6:26190199	HIST1H3E	chr6:26224427-26226589:+	0.82	5.45	2.5E-7	Renal underexcretion gout;Gout	
GBM	cis	1	rs8027260	chr15:65955172	SLC24A1	chr15:65903704-65953256:+	0.27	4.2	5.07E-5	Mean corpuscular hemoglobin	
GBM	cis	1	rs8030090	chr15:79034260	ADAMTS7	chr15:79051546-79103773:-	0.34	4.4	2.29E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs8030335	chr15:79034124	ADAMTS7	chr15:79051546-79103773:-	0.34	4.33	3.0E-5	Coronary artery disease or large artery stroke	
GBM	cis	1	rs80313145	chr6:26194965	HIST1H3E	chr6:26224427-26226589:+	0.87	4.76	5.23E-6	Renal underexcretion gout;Gout	
GBM	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.8	-6.29	4.69E-9	Type 2 diabetes	
GBM	cis	1	rs8064261	chr17:61705212	FTSJ3	chr17:61896795-61905031:-	0.45	4.96	2.25E-6	Body mass index	
GBM	cis	1	rs8066719	chr17:61825764	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs8067064	chr17:61825984	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs8067431	chr17:61817048	FTSJ3	chr17:61896795-61905031:-	0.46	5.06	1.45E-6	Body mass index	
GBM	cis	1	rs8068603	chr17:61755211	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs8069687	chr17:61883023	FTSJ3	chr17:61896795-61905031:-	-0.47	-5.17	8.81E-7	Body mass index	
GBM	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.77	-8.52	4.1E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs8070650	chr17:61744040	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs8073373	chr17:61703320	FTSJ3	chr17:61896795-61905031:-	0.43	4.77	5.04E-6	Body mass index	
GBM	cis	1	rs8074771	chr17:61735865	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs8075061	chr17:61804723	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs8075257	chr17:61728750	FTSJ3	chr17:61896795-61905031:-	0.43	4.86	3.46E-6	Body mass index	
GBM	cis	1	rs8075422	chr17:61804686	FTSJ3	chr17:61896795-61905031:-	0.45	5.05	1.53E-6	Body mass index	
GBM	cis	1	rs8075521	chr17:61804954	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.58	-6.02	1.75E-8	Metabolite levels	
GBM	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.46	-5.16	9.32E-7	Metabolite levels	
GBM	cis	1	rs8076717	chr17:61850301	FTSJ3	chr17:61896795-61905031:-	-0.46	-5.2	7.72E-7	Body mass index	
GBM	cis	1	rs8077265	chr17:61732727	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs8078462	chr17:61857937	FTSJ3	chr17:61896795-61905031:-	0.46	5.17	8.9E-7	Body mass index	
GBM	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.72	-8.2	2.3E-13	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
GBM	cis	1	rs8078862	chr17:61854068	FTSJ3	chr17:61896795-61905031:-	0.46	5.17	8.9E-7	Body mass index	
GBM	cis	1	rs8080211	chr17:61729882	FTSJ3	chr17:61896795-61905031:-	0.44	4.77	4.9E-6	Body mass index	
GBM	cis	1	rs8081541	chr17:61812483	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs8081612	chr17:61724695	FTSJ3	chr17:61896795-61905031:-	-0.42	-4.73	6.02E-6	Body mass index	
GBM	cis	1	rs8100042	chr19:22127841	ZNF257	chr19:22235266-22273901:+	0.65	4.51	1.48E-5	Body mass index (change over time)	
GBM	cis	1	rs8100392	chr19:33605933	GPATCH1	chr19:33571786-33621318:+	0.4	4.5	1.54E-5	Bone properties (heel)	
GBM	cis	1	rs8100392	chr19:33605933	RHPN2	chr19:33469499-33555824:-	-0.38	-4.24	4.27E-5	Bone properties (heel)	
GBM	cis	1	rs8104559	chr19:22205167	ZNF257	chr19:22235266-22273901:+	0.66	4.47	1.69E-5	Body mass index (change over time)	
GBM	cis	1	rs8105895	chr19:22215457	ZNF257	chr19:22235266-22273901:+	0.66	4.47	1.69E-5	Body mass index (change over time)	
GBM	cis	1	rs8110181	chr19:33605939	GPATCH1	chr19:33571786-33621318:+	0.4	4.5	1.54E-5	Bone properties (heel)	
GBM	cis	1	rs8110181	chr19:33605939	RHPN2	chr19:33469499-33555824:-	-0.38	-4.24	4.27E-5	Bone properties (heel)	
GBM	cis	1	rs8123289	chr20:3253831	ITPA	chr20:3190056-3204504:+	-0.55	-5.39	3.32E-7	IFN-related cytopenia	
GBM	cis	1	rs8125868	chr20:25324410	FAM182A	chr20:26035250-26067552:+	0.68	6.74	5.1E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.55	4.49	1.57E-5	Multiple sclerosis	
GBM	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.93	10.25	2.63E-18	Type 2 diabetes	
GBM	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.97	10.44	9.16E-19	Type 2 diabetes	
GBM	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.94	10.36	1.45E-18	Type 2 diabetes	
GBM	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.94	-10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs838705	chr2:234273242	USP40	chr2:234384166-234475428:-	-0.29	-4.34	2.91E-5	Calcium levels	
GBM	cis	1	rs8396	chr4:159630817	ETFDH	chr4:159593277-159629839:+	0.49	4.72	6.22E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
GBM	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.96	-10.54	5.14E-19	Type 2 diabetes	
GBM	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.93	10.07	7.18E-18	Type 2 diabetes	
GBM	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.84	9.12	1.48E-15	Type 2 diabetes	
GBM	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.94	10.34	1.6E-18	Type 2 diabetes	
GBM	cis	1	rs868798	chr10:64895010	NRBF2	chr10:64893007-64914785:+	0.48	4.19	5.15E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.39	6.13	1.04E-8	Kawasaki disease	
GBM	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.78	-9.52	1.64E-16	Cognitive function	
GBM	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.62	-5.6	1.26E-7	Rheumatoid arthritis	
GBM	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.17	8.95E-7	Homocysteine levels	
GBM	cis	1	rs884613	chr20:25288505	FAM182A	chr20:26035250-26067552:+	0.67	6.67	7.41E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.68	-8.77	1.04E-14	Response to antipsychotic treatment	
GBM	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.38	5.05	1.51E-6	Longevity	
GBM	cis	1	rs910997	chr20:25267301	FAM182A	chr20:26035250-26067552:+	-0.68	-6.75	4.75E-10	Liver enzyme levels (alkaline phosphatase)	
GBM	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.54	6	1.98E-8	Type 1 diabetes	
GBM	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.38	5.01	1.81E-6	Longevity	
GBM	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.93	10.19	3.81E-18	Type 2 diabetes	
GBM	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.77	6.86	2.72E-10	Blood pressure (smoking interaction)	
GBM	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.63	-6.93	1.92E-10	Plasma homocysteine levels (post-methionine load test)	
GBM	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.66	6.89	2.38E-10	Plasma homocysteine levels (post-methionine load test)	
GBM	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.57	-6.95	1.71E-10	Longevity	
GBM	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	0.77	8.72	1.36E-14	Diastolic blood pressure	
GBM	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.39	-5.25	6.24E-7	Longevity	
GBM	cis	1	rs931794	chr15:78826180	CHRNA5	chr15:78857906-78886458:+	0.45	4.22	4.55E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
GBM	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.74	-8.65	1.98E-14	Diastolic blood pressure	
GBM	cis	1	rs9410967	chr9:90411001	NXNL2	chr9:91150016-91190703:+	0.42	4.36	2.68E-5	Smoking quantity	
GBM	cis	1	rs9410	chr4:159631991	ETFDH	chr4:159593277-159629839:+	-0.49	-4.72	6.1E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
GBM	cis	1	rs9414780	chr10:65001433	JMJD1C	chr10:64926990-65225722:-	0.39	4.41	2.22E-5	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9414780	chr10:65001433	NRBF2	chr10:64893007-64914785:+	0.52	5.15	9.69E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9414799	chr10:65129602	NRBF2	chr10:64893007-64914785:+	0.59	5.31	4.82E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9414800	chr10:65131282	NRBF2	chr10:64893007-64914785:+	0.59	5.31	4.82E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9414803	chr10:65188069	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9415692	chr10:65115152	NRBF2	chr10:64893007-64914785:+	0.57	5.2	7.77E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9415696	chr10:65134348	NRBF2	chr10:64893007-64914785:+	0.59	5.31	4.87E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9415697	chr10:65135137	NRBF2	chr10:64893007-64914785:+	0.59	5.31	4.87E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9415701	chr10:65151509	NRBF2	chr10:64893007-64914785:+	0.62	5.65	1.02E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9415707	chr10:65188290	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs9415708	chr10:65190042	NRBF2	chr10:64893007-64914785:+	0.57	5.33	4.31E-7	Arthritis (juvenile idiopathic)	
GBM	cis	1	rs943461	chr6:33769409	LEMD2	chr6:33738991-33756906:-	0.4	4.7	6.72E-6	Body mass index	
GBM	cis	1	rs943462	chr6:33769578	LEMD2	chr6:33738991-33756906:-	0.4	4.7	6.72E-6	Body mass index	
GBM	cis	1	rs943466	chr6:33731787	LEMD2	chr6:33738991-33756906:-	-0.38	-4.69	6.92E-6	Body mass index	
GBM	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.67	8.24	1.87E-13	Response to antipsychotic treatment	
GBM	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.7	-8.53	3.97E-14	Response to antipsychotic treatment	
GBM	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.67	-8.51	4.26E-14	Response to antipsychotic treatment	
GBM	cis	1	rs962221	chr1:92970770	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs962222	chr1:92970953	EVI5	chr1:92974255-93257961:-	-0.54	-4.93	2.58E-6	Cholesterol, total	
GBM	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.65	-8.25	1.84E-13	Response to antipsychotic treatment	
GBM	cis	1	rs965469	chr20:3381549	ITPA	chr20:3190056-3204504:+	-0.5	-4.95	2.34E-6	IFN-related cytopenia	
GBM	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.68	8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.68	-7.63	4.92E-12	Erythrocyte sedimentation rate	
GBM	cis	1	rs9715911	chr5:156394441	TIMD4	chr5:156346293-156390266:-	-0.5	-5.37	3.64E-7	Triglycerides;Cholesterol, total;LDL cholesterol	
GBM	cis	1	rs9747164	chr17:61864787	FTSJ3	chr17:61896795-61905031:-	0.46	5.1	1.19E-6	Body mass index	
GBM	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.68	8.34	1.13E-13	Eye color traits	
GBM	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.69	8.42	7.22E-14	Eye color traits	
GBM	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.41	4.22	4.63E-5	Forced vital capacity	
GBM	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.49	5.47	2.32E-7	Pancreatic cancer	
GBM	cis	1	rs9788721	chr15:78802869	CHRNA5	chr15:78857906-78886458:+	0.48	4.58	1.08E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
GBM	cis	1	rs9804992	chr12:988894	RAD52	chr12:1021255-1099219:-	0.5	5.03	1.67E-6	Colorectal cancer	
GBM	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.4	-5.34	4.13E-7	Longevity	
GBM	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.45	6.09	1.28E-8	Longevity	
GBM	cis	1	rs9812791	chr3:49682311	LAMB2L	chr3:49190293-49191834:-	0.51	4.83	3.85E-6	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.37	-4.9	2.83E-6	Longevity	
GBM	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.75	7.77	2.41E-12	Diastolic blood pressure	
GBM	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.44	-5.85	4.0E-8	Longevity	
GBM	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs9822268	chr3:49719729	LAMB2L	chr3:49190293-49191834:-	0.48	4.52	1.38E-5	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.77	7.97	8.15E-13	Diastolic blood pressure	
GBM	cis	1	rs9823546	chr3:49705512	LAMB2L	chr3:49190293-49191834:-	0.48	4.52	1.38E-5	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.77	7.97	8.15E-13	Diastolic blood pressure	
GBM	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.79	-8.52	4.18E-14	Diastolic blood pressure	
GBM	cis	1	rs9826058	chr3:41762062	ULK4	chr3:41288091-42003660:-	0.79	8.39	8.44E-14	Diastolic blood pressure	
GBM	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.4	-5.34	4.13E-7	Longevity	
GBM	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.76	9.01	2.8E-15	Diastolic blood pressure	
GBM	cis	1	rs9830469	chr3:41762535	ULK4	chr3:41288091-42003660:-	0.79	8.25	1.79E-13	Diastolic blood pressure	
GBM	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	0.74	8.45	6.01E-14	Diastolic blood pressure	
GBM	cis	1	rs9836053	chr3:150885877	CLRN1OS	chr3:150570271-150797617:+	-0.61	-4.23	4.54E-5	Heschl's gyrus morphology	
GBM	cis	1	rs9836291	chr3:49697459	LAMB2L	chr3:49190293-49191834:-	0.53	4.98	2.02E-6	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.41	-5.52	1.81E-7	Longevity	
GBM	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-0.73	-8.6	2.65E-14	Diastolic blood pressure	
GBM	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-0.73	-8.6	2.65E-14	Diastolic blood pressure	
GBM	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	0.7	7.78	2.23E-12	Diastolic blood pressure	
GBM	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.74	8.72	1.35E-14	Diastolic blood pressure	
GBM	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.4	-4.63	9.0E-6	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
GBM	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.73	-8.61	2.52E-14	Diastolic blood pressure	
GBM	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-0.79	-9.28	6.19E-16	Diastolic blood pressure	
GBM	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.77	7.97	8.15E-13	Diastolic blood pressure	
GBM	cis	1	rs9847006	chr3:41755359	ULK4	chr3:41288091-42003660:-	0.83	8.92	4.62E-15	Diastolic blood pressure	
GBM	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.78	7.8	2.03E-12	Diastolic blood pressure	
GBM	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.86	8.55	3.51E-14	Diastolic blood pressure	
GBM	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.44	-5.83	4.31E-8	Longevity	
GBM	cis	1	rs9852303	chr3:41759525	ULK4	chr3:41288091-42003660:-	0.79	8.39	8.44E-14	Diastolic blood pressure	
GBM	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.79	7.82	1.81E-12	Diastolic blood pressure	
GBM	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	0.77	8.72	1.36E-14	Diastolic blood pressure	
GBM	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.72	8.03	5.87E-13	Diastolic blood pressure	
GBM	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.79	8.95	3.76E-15	Diastolic blood pressure	
GBM	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.71	8.26	1.67E-13	Diastolic blood pressure	
GBM	cis	1	rs9858213	chr3:49731861	LAMB2L	chr3:49190293-49191834:-	0.49	4.62	9.3E-6	Educational attainment	
GBM	cis	1	rs9863915	chr3:41762002	ULK4	chr3:41288091-42003660:-	0.79	8.39	8.44E-14	Diastolic blood pressure	
GBM	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.75	7.45	1.32E-11	Diastolic blood pressure	
GBM	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.4	-5.35	3.94E-7	Longevity	
GBM	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	0.77	8.65	1.98E-14	Diastolic blood pressure	
GBM	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs9866759	chr3:41758418	ULK4	chr3:41288091-42003660:-	0.83	9.09	1.81E-15	Diastolic blood pressure	
GBM	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.8	-7.92	1.08E-12	Diastolic blood pressure	
GBM	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.74	8.75	1.16E-14	Diastolic blood pressure	
GBM	cis	1	rs9869282	chr3:41756064	ULK4	chr3:41288091-42003660:-	0.83	8.92	4.62E-15	Diastolic blood pressure	
GBM	cis	1	rs9869440	chr3:41763155	ULK4	chr3:41288091-42003660:-	0.79	8.25	1.79E-13	Diastolic blood pressure	
GBM	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.76	7.96	8.67E-13	Diastolic blood pressure	
GBM	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.76	7.96	8.67E-13	Diastolic blood pressure	
GBM	cis	1	rs9874975	chr3:41764300	ULK4	chr3:41288091-42003660:-	0.84	8.67	1.76E-14	Diastolic blood pressure	
GBM	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.79	7.82	1.81E-12	Diastolic blood pressure	
GBM	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.69	8.04	5.71E-13	Diastolic blood pressure	
GBM	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.42	-5.62	1.18E-7	Longevity	
GBM	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-0.77	-9	2.93E-15	Diastolic blood pressure	
GBM	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.41	-5.51	1.91E-7	Longevity	
GBM	cis	1	rs9882329	chr3:41767154	ULK4	chr3:41288091-42003660:-	0.84	8.7	1.54E-14	Diastolic blood pressure	
GBM	cis	1	rs9882740	chr3:49702484	LAMB2L	chr3:49190293-49191834:-	0.47	4.44	1.94E-5	Crohn's disease;Ulcerative colitis	
GBM	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.42	-5.74	6.78E-8	Longevity	
GBM	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.44	-5.84	4.19E-8	Longevity	
GBM	cis	1	rs9891018	chr17:61827856	FTSJ3	chr17:61896795-61905031:-	0.46	5.11	1.19E-6	Body mass index	
GBM	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.7	8.39	8.23E-14	Eye color traits	
GBM	cis	1	rs9895920	chr17:61852719	FTSJ3	chr17:61896795-61905031:-	0.46	5.16	9.47E-7	Body mass index	
GBM	cis	1	rs9899491	chr17:61934384	FTSJ3	chr17:61896795-61905031:-	0.48	5.51	1.97E-7	Body mass index	
GBM	cis	1	rs9899788	chr17:61756384	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs9901112	chr17:61730617	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs9901507	chr17:61765524	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs9903897	chr17:61716705	FTSJ3	chr17:61896795-61905031:-	0.43	4.77	5.04E-6	Body mass index	
GBM	cis	1	rs9903903	chr17:61762044	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs9908044	chr17:61747032	FTSJ3	chr17:61896795-61905031:-	0.43	4.76	5.17E-6	Body mass index	
GBM	cis	1	rs9909992	chr17:61731931	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs9912201	chr17:61763208	FTSJ3	chr17:61896795-61905031:-	0.44	4.83	3.85E-6	Body mass index	
GBM	cis	1	rs9912904	chr17:61763534	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs9918016	chr4:159621997	ETFDH	chr4:159593277-159629839:+	-0.5	-4.78	4.82E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
GBM	cis	1	rs9920421	chr15:90368067	AP3S2	chr15:90373832-90456222:-	-0.72	-5.88	3.46E-8	Type 2 diabetes	
GBM	cis	1	rs9920762	chr15:90368171	AP3S2	chr15:90373832-90456222:-	-0.74	-6.04	1.58E-8	Type 2 diabetes	
GBM	cis	1	rs9920775	chr15:90368273	AP3S2	chr15:90373832-90456222:-	-0.73	-5.95	2.47E-8	Type 2 diabetes	
GBM	cis	1	rs992416	chr17:61745905	FTSJ3	chr17:61896795-61905031:-	0.45	4.95	2.3E-6	Body mass index	
GBM	cis	1	rs9925964	chr16:31129895	MYST1	chr16:31128985-31142713:+	-0.39	-4.46	1.78E-5	Body mass index	
GBM	cis	1	rs9938862	chr16:67723801	LRRC36	chr16:67360747-67419108:+	0.82	4.38	2.49E-5	Crohn's disease	
GBM	cis	1	rs9939085	chr16:67733237	LRRC36	chr16:67360747-67419108:+	0.82	4.38	2.49E-5	Crohn's disease	
GBM	cis	1	rs9988866	chr11:18392983	GTF2H1	chr11:18343816-18388590:+	0.46	4.99	1.93E-6	Pancreatic cancer	
GBM	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.57	-6.95	1.71E-10	Longevity	
GBM	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.74	8.1	4.1E-13	Educational attainment	
GBM	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.76	8.04	5.48E-13	Educational attainment	
GBM	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.6E-13	Educational attainment	
GBM	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.75	8.25	1.77E-13	Educational attainment	
GBM	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.75	8.25	1.77E-13	Educational attainment	
GBM	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.75	8.25	1.77E-13	Educational attainment	
GBM	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.67E-13	Educational attainment	
GBM	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.75	8.25	1.77E-13	Educational attainment	
GBM	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.69E-13	Educational attainment	
GBM	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.74	8.1	4.1E-13	Educational attainment	
GBM	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.69E-13	Educational attainment	
GBM	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.69E-13	Educational attainment	
GBM	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.76	8.04	5.48E-13	Educational attainment	
GBM	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.8	8.35	1.05E-13	Educational attainment	
GBM	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.75	8.25	1.77E-13	Educational attainment	
GBM	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.75	8.25	1.77E-13	Educational attainment	
GBM	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.76	8.04	5.48E-13	Educational attainment	
GBM	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.76	8.04	5.48E-13	Educational attainment	
GBM	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.75	8.26	1.71E-13	Educational attainment	
GBM	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.74	8.1	3.96E-13	Educational attainment	
GBM	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.69E-13	Educational attainment	
GBM	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.74	7.9	1.21E-12	Educational attainment	
GBM	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.75	8.26	1.71E-13	Educational attainment	
GBM	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.73	-7.81	1.88E-12	Educational attainment	
GBM	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.6E-13	Educational attainment	
GBM	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.75	8.26	1.71E-13	Educational attainment	
GBM	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.6E-13	Educational attainment	
GBM	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.74	7.9	1.21E-12	Educational attainment	
GBM	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.6E-13	Educational attainment	
GBM	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.75	8.27	1.62E-13	Educational attainment	
GBM	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.75	-8.26	1.71E-13	Educational attainment	
GBM	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.76	8.35	1.03E-13	Educational attainment	
GBM	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.76	8.04	5.48E-13	Educational attainment	
GBM	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.75	8.26	1.71E-13	Educational attainment	
GBM	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.75	8.25	1.77E-13	Educational attainment	
GBM	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.75	8.25	1.77E-13	Educational attainment	
GBM	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.76	8.04	5.48E-13	Educational attainment	
GBM	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.74	7.9	1.21E-12	Educational attainment	
GBM	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.76	8.04	5.48E-13	Educational attainment	
GBM	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.75	8.25	1.77E-13	Educational attainment	
GBM	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.74	-8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.73	7.91	1.13E-12	Educational attainment	
GBM	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
GBM	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.7	-7.3	2.91E-11	Educational attainment	
GBM	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.69E-13	Educational attainment	
GBM	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.74	8.12	3.69E-13	Educational attainment	
GBM	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.74	8.09	4.36E-13	Educational attainment	
